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 The majority of the neurons in the mammalian cerebral cortex are glutamatergic 
excitatory neurons that have a specific migration pattern and a well-defined ‘pyramidal’ 
morphology.  Pyramidal neurons migrate on a radial glia scaffold to reach a layer-specific 
destination in the cortex and extend two polarized processes: the apical dendrite and the 
axon.  Defining molecular mechanisms of migration and morphogenesis are key to 
understanding circuit formation in the developing cortex.  
 Recent studies have demonstrated that GSK-3 has a critical role in controlling 
neuronal number through regulation of radial progenitor proliferation and intermediate 
precursor amplification.  However, only in vitro work has addressed GSK-3 functions related 
to cortical neuronal morphogenesis.  The primary conclusion has been that, downstream of 
RTK/PI3K pathways, GSK-3 inhibition favors axon specification over dendrite formation.  
Often, in vitro studies cannot be recapitulated in vivo.  For my thesis, I have generated mouse 
lines that allow for the in vivo deletion of GSK-3 in newly born excitatory neurons of the 
cerebral cortex.
 I have identified a cell autonomous requirement for GSK-3 signaling in neuronal 
migration.  GSK-3 regulation is specific for radial migration as tangential migration is not 
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ABSTRACT
Meghan Morgan-Smith: GSK-3 Regulation of Migration and Morphogenesis in the 
Developing Cortex
(Under the direction of William D. Snider)  
affected.  Additionally, GSK-3 signaling regulates key aspects of morphogenesis including 
development of the apical dendrite and orientation of the basal arbor.  Interestingly, GSK-3 
regulation of migration is not mediated by β-catenin signaling and appears to be independent 
of the RTK/PI3K pathways.  Rather, I find strong reductions in phosphorylation of two 
microtubule associated proteins: the migration mediator Doublecortin and the semaphorin 
signaling mediator CRMP-2.  Further, the abnormalities in dendritic morphology I describe 
bear similarities to abnormal semaphorin signaling.  
  I conclude that GSK-3 signaling is essential for proper circuit formation and 
connectivity in the developing cerebral cortex via regulation of neuronal migration and 
polarized morphological elaboration.  I further demonstrate that GSK-3 regulation of 
developing cortical neurons is through a signaling cascade that is distinct from regulation of 
progenitor homeostasis.  My work emphasizes the importance of GSK-3 signaling in 
multiple aspects of the development of the mammalian cerebral cortex. 
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CHAPTER 1: INTRODUCTION
   The proper development of the cerebral cortex underlies the connectivity required 
for cortical function.  I have been fascinated by several aspects of this process including 
neuronal migration, layer formation and early aspects of neuronal morphogenesis since 
BBSP interview weekend where Dr. Sabrice Guerrier, then a graduate student of the Polleux 
Lab, presented a movie of migrating cortical neurons.  
 Several recent advances have made it particularly exciting to study cortical 
development.  First, mutations in humans and mice that result in layer formation deficits 
provide clues to the molecular basis of neuronal migration.  Second, the development of 
techniques including mouse mutagenesis and in utero electroporation allow for decisive 
testing of protein function in vivo.  Finally, the development of cell biological methods now 
allows for detailed visualization of neurodevelopmental events including the visualization of 
migrating neurons in real-time.
 In both the Polleux and Snider labs I have worked on master kinases that are key 
regulators of cortical neuronal development.  Of particular note, and the main subject of my 
thesis, is Glycogen Synthase Kinase-3 (GSK-3).  GSK-3 signaling has been implicated in the 
Reelin pathway, probably the best known molecular regulator of migration in the cortex.  
Further, GSK-3 regulates key microtubule binding proteins like Doublecortin (DCX) and 
collapsin response mediated protein 2 (CRMP-2), which are known to be important in 
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migration.  Interestingly, cyclin dependent kinase 5 (CDK5), a kinase already known to be 
important in migration shares many substrates with GSK-3.  Finally, GSK-3 is a key 
mediator in the semaphorin pathway that is known, from Franck Polleux’s work, to regulate 
apical dendrite morphology.
 Work from our lab and others have defined a role for GSK-3 in the regulation of 
neuronal progenitors (Kim, Wang et al. 2009; Fang, Chen et al. 2013).  To date there is no 
mouse genetic work on the functions of GSK-3 in early developing cortical neurons.  
Defining GSK-3 functions will be very important given that GSK-3 functions in that pathway  
by which the schizophrenia associated protein, DISC-1, functions in brain development.
 As an introduction to this subject matter, Chapter 2 will provide a review of cortical 
development while Chapter 3 will summarize and GSK-3 signaling.  In Chapter 4, I present a 
study on cortical developmental functions of TAK1, a kinase upstream of LKB1 (my work 
under the supervision of Franck Polleux).  The primary focus of my thesis is Chapter 5, 
‘GSK-3 regulation of migration and morphogenesis in the developing cortex’.  This chapter 
is formatted as a manuscript to be submitted to eLIFE within the next few weeks.  Finally, 
Chapter 6 is a discussion of future directions that may spring from my thesis work.
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CHAPTER 2: Cortical Development
2.1  Overview
 The development of the mammalian neocortex is dependent on precisely timed and 
regulated neurogenesis, cell polarization, migration and morphological development.  These 
processes are the framework for proper circuit connectivity and function.  Defining the 
molecular regulation by GSK-3, or any other protein, requires detailed understanding of the 
timing and nature of these sequential steps in building the cortex.   In this chapter I briefly 
present a summary of murine cortical development relevant to the experimental findings 
described in my main paper (Chapter 5).  The original literature in this area is vast.  I have 
selectively cited some of the original papers as well as some recent comprehensive reviews.  
Importantly, a new three-volume series ‘Comprehensive Developmental Neuroscience’ edited 
by John Rubinstein and Pasko Rakic contains a volume dedicated to cellular migration and 
circuit formation with several outstanding chapters that summarize the current state of 
thinking. 
2.2 Rodent and Primate Models
 The cerebral cortex is a highly evolved and complex structure that is essential for the 
more evolved functions of the human brain.  Two functional classes of neurons are present in 
the mammalian cerebral cortex, excitatory pyramidal neurons and inhibitory interneurons.  
Pyramidal neurons compose approximately 80% of the neurons in the cortex and are 
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responsible for the excitatory glutamatergic signaling, while interneurons are responsible for 
inhibitory GABAergic signaling (for review see Rubenstein 2011).  If the processes that 
regulate key aspects of pyramidal neuronal development are disrupted, structural brain 
malformations and developmental delay can result, as well as more subtle abnormalities that 
underlie disorders like schizophrenia  (Mochida and Walsh 2004; Kumar, Sundaram et al. 
2010). 
  An important point for mouse work is that rodent and primate models exhibit 
similarities to humans in progenitor regulation, migratory patterns, and neuronal maturation 
(Molnar, Metin et al. 2006). This similarity makes mouse genetic studies useful for defining 
the mechanisms underlying cortical development in humans.  Importantly, many human 
symptoms and disease states can be analyzed in genetically modified mouse models.  
 Though both rodent and primate cortical development have similar patterns, a vast 
increase in cortical volume is associated with more evolved species (Krubitzer and Kaas 
2005).  While rodents lack a folded cortex (lissenencephalic), the primate cortex is gyrated 
due to a massive increase in cell number (Willis 1664).  This difference is largely due to the 
enlarged progenitor area known as the outer subventricular zone, which is vastly enlarged in 
primates (Smart, Dehay et al. 2002; Hansen, Lui et al. 2010).  However, the cell types present 
and overall process of cortical development are similar between primates and rodents (for 
review see Molnar 2011).  This similarity makes genetic manipulation and elucidation of 
cortical circuit and function in the mouse model appropriate for our understanding of the 
development of the cortices of all mammals. 
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2.3  Progenitor Proliferation and Lamination 
 The development of the murine neocortex begins around embryonic day 10 (E10)
(Angevine 1970; Borrell and Reillo 2012).  At this time the neural progenitor cells (NPCs) 
symmetrically divide to expand the progenitor pool of radial glial cells located in the 
ventricular zone (VZ) (Haubensak, Attardo et al. 2004; Kriegstein and Alvarez-Buylla 2009).  
Radial glia are a specialized cell type that have cell bodies located in the VZ with long basal 
processes reaching the pial surface and shorter apical processes with end-feet near the 
ventricle (Schmechel and Rakic 1979; Ayala, Shu et al. 2007) (for recent progenitor review 
see Borrell and Reillo, 2012) [Figure 2.2].  Radial glia cells were originally described in 
small mammals and human fetuses by Giuseppe Magini and Camillo Golgi in the mid-late 
1800‘s (see Bentivogolio and Mazzarello, 1999 for a historical review) and were originally 
thought to provide a scaffold for neuronal migration (Rakic 1971; Rakic 1972).  A major 
advance in the 2000s was the demonstration that in mice, radial glia are the progenitor pool 
for most of the neurons and glia in the cerebral cortex (Noctor, Flint et al. 2001; Lui, Hansen 
et al. 2011).  
 The neurogenic phase of cortical development begins from E10.5 to E12 (Ayala, Shu 
et al. 2007).  During this time the radial glia cells asymmetrically divide to form a daughter 
radial glial cell and a newly born glutamatergic pyramidal neuron (Angevine and Sidman 
1961; Noctor, Flint et al. 2001; Evsyukova, Plestant et al. 2013).  Important to my thesis 
work, radial progenitor proliferation is strongly regulated by GSK-3 (Kim, Wang et al. 2009), 
see Chapter 3. 
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 Beginning around E14.5 radial glia cells also divide to form intermediate progenitor 
cells (IPCs) which migrate and populate the subventricular zone (Noctor, Martinez-Cerdeno 
et al. 2004).  These transient progenitors symmetrically divide into daughter IPCs or daughter 
neurons with intracortical projections (Noctor, Martinez-Cerdeno et al. 2004; Noctor, 
Martinez-Cerdeno et al. 2008; Kriegstein and Alvarez-Buylla 2009).  Both the symmetric 
divisions of IPCs and the asymmetric divisions of radial glia progenitors are responsible for 
the rapid expansion of the cortex (Smart, Dehay et al. 2002; Hansen, Lui et al. 2010).  A 
recent study has identified a new role for GSK-3 in IPC amplification (Fang, Chen et al. 
2013).  This work further solidifies a role for GSK-3 in regulating progenitors and 
controlling neuronal numbers in the developing cortex.       
 The neocortex is a highly laminated structure made of six layers.  Each layer is 
identifiable by molecular markers and pyramidal cell morphology (DeFelipe and Farinas 
1992; Hevner, Daza et al. 2003; Molyneaux, Arlotta et al. 2007).  Importantly, the laminar 
fate of newly born neurons is dependent on the timing of radial glia cell division.  Beginning 
around E10.5, the first born immature neurons migrate towards the pial surface to form the 
transient preplate, the beginning of the cortex (Gupta, Tsai et al. 2002; Nadarajah and 
Parnavelas 2002) [Figure 2.1].  Ultimately some these cells will become the most superficial 
layer of the cortex, layer 1, containing Cajal-Retzius cells that secrete Reelin to regulate 
migration (see below) (D'Arcangelo, Miao et al. 1995).  Recently, a study has suggested that 
some radial glia cell have specified neuronal fates, arguing that both timing and specific 
radial glia subtypes are responsible for the lamination of the cortex (Franco, Gil-Sanz et al. 
2012).
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 Newly generated neurons fated to form the laminated cortex are born around E12.5 
and migrate to split the preplate and form the beginning of cortical plate (CP) [Figure 2.1] 
(for review see Evsyukova et al, 2013).  These first neurons will form the deepest layer of the 
cortex, layer 6, while the preplate cells transition into the marginal zone and subplate (Marin-
Padilla 1978; Gupta, Tsai et al. 2002; Molyneaux, Arlotta et al. 2007) [Figure 2.1].  Later 
born neurons will enter the cortical plate and migrate past previously born neurons to 
populate the outermost positions in the developing cortex, layers 2-5 [Figure 2.1].     
 The developmental sequence of birth and migration past existing neurons continues 
until E18 and gives the cortex an ‘inside-out’ lamination where the oldest neurons populate 
the deepest layers and the youngest neurons are located towards the pial surface (Angevine 
and Sidman 1961; Angevine 1970; Rakic 1974; Marin-Padilla 1978).  After E18, radial glia 
cells retract their processes and differentiate into astrocytes (Mission, Takahashi et al. 1991; 
Kriegstein and Alvarez-Buylla 2009; Li, Newbern et al. 2012).  At this stage the neurons 
finish migration, extend axons to their targets, and develop dendrite arbors.  Ultimately the 
subplate degenerates and the six-layered cortex remains through adulthood (Luskin and Shatz 
1985; Allendoerfer and Shatz 1994).
 In addition to the excitatory pyamidal neurons of the neocortex, inhibitory 
GABAergic interneurons also populate the cortex.  These neurons are born outside of the 
cortex in the medial ganglionic eminence (MGE) and migrate into the cortex beginning at 
E12.5 (Parnavelas, Barfield et al. 1991; Anderson, Eisenstat et al. 1997; Jimenez, Lopez-
Mascaraque et al. 2002).  As with excitatory neurons, interneurons also populate all layers of 
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the cortex.  Interestingly, I have found important differences in GSK-3 regulation of 
excitatory versus inhibitory neurons.
2.4  Neuronal Migration
 Migration at the earliest stages of cortical development is characterized by somal 
translocation.  First characterized in the opossum, early born neurons from E10-E12 form the 
primordial plexiform layer, or preplate, and extend a leading edge to the pial surface 
(Allendoerfer and Shatz 1994; Nadarajah, Brunstrom et al. 2001; Nadarajah and Parnavelas 
2002).  The soma then translocates out of the VZ and the neuron retracts the apical process 
that is extended to the ventricular zone (Morest 1970; Brittis, Meiri et al. 1995; Nadarajah, 
Brunstrom et al. 2001; Marin and Rubenstein 2003) [Figure 1.2A].   This initial form of 
migration does not require the use of a radial glia scaffold, occurs in a smooth and continuous 
motion, and is not the primary mode of migration by the majority of neurons that will 
populate the cortical plate (Nadarajah, Brunstrom et al. 2001; Evsyukova, Plestant et al. 
2013).  However, somal translocation does occur as the final stage of the second mode of 
migration, glial-guided migration (Nadarajah, Brunstrom et al. 2001; Marin and Rubenstein 
2003).
 The second form of migration, first identified in fetal monkey neocortex, is known as 
glial-guided migration or locomotion (Rakic 1971; Rakic 1972).  An immature multipolar 
neuron derived from a radial glial precursor will migrate to the SVZ, and occasionally back 
to the VZ, where it extends and retracts neurites (Tabata and Nakajima 2003; Noctor, 
Martinez-Cerdeno et al. 2004; LoTurco and Bai 2006; Tabata, Kanatani et al. 2009) [Figure 
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2.2A].  These dynamic neurites are thought to sense the local environment for a polarizing 
cue.  The multipolar neuron will then polarize and transition to a bipolar morphology 
consisting of a short leading process extending towards the pial surface, and a thin trailing 
process that will become the axon [Figure 2.2A] (Brittis, Meiri et al. 1995; Nadarajah, 
Brunstrom et al. 2001). The bipolar morphology allows for radial glia attachment and guided 
directional migration (for migration reviews see Marin and Rubenstein, 2003, Gupta et al. 
2002, Evsyukova et al, 2013).  Neurons migrating in this fashion often move in short bursts, 
a saltatory migration, with long periods of pause between movement (Nadarajah, Brunstrom 
et al. 2001).   Successive waves of newly generated neurons migrate into the cortical plate 
using this glial-guided locomotion to form the laminated structure of the cortex.  
  Inhibitory interneurons use a third form of migration, tangential migration, to 
populate the cortical plate [Figure 2.2B].  These neurons migrate into the cortex in two 
streams through the marginal zone or subplate (DeDiego, Smith-Fernandez et al. 1994; 
Anderson, Eisenstat et al. 1997; Lavdas, Grigoriou et al. 1999; Anderson, Marin et al. 2001).  
These cells migrate tangentially to the radial glia cells in the cortex and do not rely on radial 
glia interactions to populate the cortical plate (Anderson, Eisenstat et al. 1997; Corbin, Nery 
et al. 2001; Marin and Rubenstein 2003; Yokota, Gashghaei et al. 2007).  Instead, these 
neurons use a combination of interactions with axons, dendrites and radial glia to reach their 
final positions (Polleux and Ghosh 2002).  Interneurons often change direction and extend 
and retract leading processes (Kriegstein and Noctor 2004).  However, once these cells reach 
the cortex they invade all layers in a radial fashion, but without proper leading edge 
orientation along the radial glia scaffold (Polleux, Whitford et al. 2002; Ang, Haydar et al. 
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2003; Marin and Rubenstein 2003).  Importantly, radial and tangential migration are thought 
to be regulated quite differently (see below).       
 All neuronal movements require complex and precise regulation of cytoskeletal 
dynamics.  Specifically, the highly dynamic multipolar state, transition to bipolar 
morphology, and physical movement along radial glia require especially fine control of 
cytoskeletal dynamics [Figure 2.3].  As such, many microtubule associated proteins (MAPS) 
have been identified as regulators of migration.  These include key proteins like Doublecortin 
(DCX) (des Portes, Pinard et al. 1998; Gleeson, Allen et al. 1998; Friocourt, Liu et al. 2007; 
Bilimoria, de la Torre-Ubieta et al. 2010), LIS1 (Tsai, Chen et al. 2005), MAP1B (Gonzalez-
Billault, Del Rio et al. 2005; Trivedi, Marsh et al. 2005) and CRMP2 (Yoshimura, Kawano et 
al. 2005; Ip, Shi et al. 2012).  Importantly for my thesis work, many of these MAPs are 
GSK-3 targets and several are also targets of the known migration regulator CDK5 (Tanaka, 
Serneo et al. 2004; Li, Hawkes et al. 2006; Xie, Samuels et al. 2006)(See Chapter 3 and 5).  
 In conjunction with cytoskeletal dynamics, adhesive molecules are also required for 
adherence to the radial glia and migration along its fibers (for adhesion review see Solecki 
2012).  Adhesion molecules must be inserted in the membrane at the leading edge and also 
removed from the cell body and trailing process to enable the cell to migrate to the pial 
surface (Solecki 2012) [Figure 2.3].  For this to occur the cell must regulate endocytosis in 
specific compartments (Shieh, Schaar et al. 2011).  Interestingly, GSK-3 has been shown to 
regulate dynamin phosphorylation (Clayton, Sue et al. 2010) and bulk endocytosis in cultured 
neurons.  Finally, in addition to adhesion, force-generating acto-myosin contractility is 
required to facilitate migration (Valiente and Marin 2010; Trivedi and Solecki 2011). 
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 To cease migration the neuron senses the appropriate ‘stop’ signal to detach from the 
radial glia cell and somally translocate to reach its final position (Nadarajah, Brunstrom et al. 
2001) (see Evsyukova et al. 2013 for review).  The major signaling molecule associated with 
ceasing migration is the glycoprotein Reelin.  Reelin is secreted from the Cajal-Retzius cells 
located in the marginal zone and is essential for splitting the preplate and the termination of 
migration (D'Arcangelo, Miao et al. 1995; Ogawa, Miyata et al. 1995; Franco and Muller 
2011; Evsyukova, Plestant et al. 2013).  In the absence of Reelin, neurons are unable to split 
the preplate or migrate past previously born neurons (D'Arcangelo, Miao et al. 1995; Ogawa, 
Miyata et al. 1995; Evsyukova, Plestant et al. 2013).  Again important for my thesis work, 
GSK-3, CDK5 and the adherence molecule N-cadherin have been implicated downstream of 
Reelin signaling (Beffert, Morfini et al. 2002; Gonzalez-Billault, Del Rio et al. 2005; Jossin 
and Cooper 2011).
 
2.5  Axon and Dendrite Formation 
 During migration, neurons rapidly develop a polarized morphology that facilitates 
axonal and dendritic elaboration and targeting.  In vivo the axon arises from the trailing 
process during neuronal migration (Rakic 1972; Schwartz, Rakic et al. 1991; Barnes, Solecki 
et al. 2008).  However, much of our knowledge of axon initiation comes from dissociated 
culture paradigms (Dotti and Banker 1987; Lewis, Courchet et al. 2013).  In the favored 
model of dissociated embryonic hippocampal neurons, multipolar neurons extend and retract 
their neurites until a single neurite elongates to form an axon (Dotti and Banker 1987; Dotti, 
Sullivan et al. 1988) [Figure 2.3].  This process is regulated by multiple kinases responsible 
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for regulating motor proteins, membrane trafficking and signal transduction.  For example, 
PI3K (Shi, Jan et al. 2003), LKB1 (Barnes, Lilley et al. 2007; Shelly, Cancedda et al. 2007) 
and GSK-3 (Shi, Cheng et al. 2004) regulate polarization in vitro through signals transduced 
to downstream substrates.  In vitro results are now being addressed using in vivo models.  For 
example, deletion of LKB1 in progenitors gives rise to neurons that are unable to form an 
axon in vivo (Barnes, Lilley et al. 2007).  In contrast, in vivo deletion of GSK-3 in cortical 
progenitors keeps progenitors in a proliferative state (Kim, Wang et al. 2009)(see below).  
Therefore neuronal morphogenesis was not assessed in the initial study of effects of GSK-3 
deletion on neuronal development in vivo.
 Each layer of the cortex contains pyramidal neurons with a specific morphology and 
projection pattern.  Briefly, deeper layers of the cortex project subcortically while upper 
layers project intracortically (Gaspard and Vanderhaeghen 2011; Deboer, Kraushar et al. 
2013).  More specifically, layer VI neurons extend corticothalamic projections while layer V 
neurons develop mostly corticobulbar, coticospinal and corticotectal projection patterns with 
a few callosally projecting neurons mixed in (Hallman, Schofield et al. 1988; Molnar and 
Cheung 2006; Deboer, Kraushar et al. 2013) [Figure 2.4].  Layer IV neurons receive sensory 
input from thalamocortical axons and project short-range axons to cortical targets (Gaspard 
and Vanderhaeghen 2011).  Neurons in the outermost layer II-III, and the focus of my thesis 
work, project contralaterally through the corpus callosum as well as within the same cortical 
hemisphere (Molyneaux, Arlotta et al. 2007; Deboer, Kraushar et al. 2013). 
 Axonal targeting after initial polarization has been studied in multiple model systems 
and several diffusible cues have been identified.  Receptors in the growth cone respond to 
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chemoattractant and chemorepulsive cues that enable proper targeting.  Netrin is an axon 
chemoattractant and required for the formation of commisures in the spinal cord and the 
corpus callosum (Lai Wing Sun, Correia et al. 2011; Fothergill, Donahoo et al. 2013).  
Interestingly, Netrin signaling can act as both a chemoattractant and a chemorepellant 
(Colamarino and Tessier-Lavigne 1995).  In the cortex, semaphorin-neuropilin1 (Luo, Raible 
et al. 1993; Pasterkamp 2012) ligand receptor signaling acts as a repulsive cue for developing 
axons.  Dual purpose signaling is also evident in semaphorin signaling where semaphorin 3A 
can act as a chemoattractant for apical dendrites of cortical pyramidal neurons and a repellant 
for their axons (see below) (Polleux, Morrow et al. 2000).
 Morphological development of pyramidal neurons and radial migration are closely 
associated processes.  At the most basic level, during radial-guided migration the leading 
process will become the apical dendrite and project towards the pial surface (Miller 1981).  
Branching of the apical dendrites occurs mostly far away from the cell soma in the apical tuft  
located in the marginal zone.  Thinner basal dendritic arbors will develop later and branch 
robustly in the area near the cell soma (Jan and Jan 2001).  Several signaling cascades have 
been identified as regulators of dendrite formation and arborization.  Among these signals, 
diffusible semaphorins have been identified as key signals required for apical dendrite 
orientation (Polleux, Morrow et al. 2000; Jan and Jan 2001; Pasterkamp 2012).  Semaphorin 
3A signaling through its receptor, neuropilin-1 and cofactor soluble guanylate cyclase, 
attracts the leading edge of a bipolar neuron causing extension towards the pial surface and 
maturation into an apical process.  Remarkably semaphorin signaling acts on the axon to 
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repel its growth away from the pial surface (Song, Ming et al. 1998; Polleux, Morrow et al. 
2000) (see chapter 3).  
 Importantly for my thesis, GSK-3 has been implicated downstream of semaphorin 
signaling (see chapter 3).  
2.6  Disruptions in Early Cortical Development 
 In human syndromes, mispositioned neurons in the cerebral cortex can result from 
changes in progenitor cell cycle or migration failure.  In humans the disruption of neuronal 
migration can result in developmental delays, seizures and death.  For example, classic 
lissencephaly is the result of improper neuronal migration and is characterized by widely 
separated or absent gyri, decreased cortical lamination and multipolar or inverted neuronal 
morphology (Kerjan and Gleeson 2007).  Groundbreaking genetic studies in humans have 
identified several genes mutated in migration disorders: LIS1 (Miller-Dieker syndrome, Type 
I lissencephaly) (Reiner, Carrozzo et al. 1993), doublecortin (X-linked lissencephaly, type I 
lissencephaly) (des Portes, Pinard et al. 1998; Gleeson, Allen et al. 1998) or tubulin α 1A 
(TUBA1) (Keays, Tian et al. 2007).  These genes have been deleted in mouse models for 
studies on the mechanisms of migration (Dobyns, Reiner et al. 1993; Forman, Squier et al. 
2005; Jaglin and Chelly 2009). 
 Human Reelin-linked lissencephaly (Norman-Roberts Syndrome) is another form of 
lissencephaly that is characterized my abnormal lamination (Hong, Shugart et al. 2000).  
Reelin, a secreted glycoprotein from the Cajal Retzius cells, signals through Dab1 for proper 
lamination of the cerebral cortex, hippocampus and cerebellum (Rice and Curran 2001; 
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Lakatosova and Ostatnikova 2012).  Mutations in this pathway lead to altered neuronal 
morphology and cortical lamination and can be studied using the classic mouse model, the 
Reeler mouse (Tissir and Goffinet 2003; Lakatosova and Ostatnikova 2012).
 Importantly for my thesis work, many of the proteins implicated in lissencephaly 
converge onto the GSK-3 regulatory hub.  Reelin has been shown to increase 
phosphorylation of an inhibitory GSK-3 site, serine 9/21 (Beffert, Morfini et al. 2002) 
decreasing the phosphorylation of tau.  However, reelin also induces the phosphorylation of 
GSK-3 on an activating tyrosine residue (Tyr216) which correlates with increased 
phosphorylation of MAP1B (Gonzalez-Billault, Del Rio et al. 2005).  These data suggest 
GSK-3 regulation of cytoskeletal dynamics may be influenced by Reelin signaling in 
complex ways.  Additionally, GSK-3 mediated phosphorylation of DCX is thought to be 
required for DCX’s actions in restricting axon branching (Bilimoria, de la Torre-Ubieta et al. 
2010) and migration (Bai, Ramos et al. 2003).  Finally, inactivation of GSK-3 by Disrupted 
In Schizophrenia-1 (DISC1) is essential for progenitor proliferation and cortical neuronal 
migration.  Abnormal regulation of GSK-3 by mutated DISC1 may underly the development 
of schizophrenia and bipolar disorder (Mao, Ge et al. 2009).
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2.7 FIGURES AND FIGURE LEGENDS
Figure 2.1 Cortical Development.
 During the neurogenic phase of cortical development radial glia cells asymmetrically  
give rise to the first neurons that form the preplate (PP) (green circles and diamonds).  The 
next generation of neurons (blue circles) splits the PP into the marginal zone (MZ) (green 
circles) and subplate (SP) (green diamonds).  The neurons that split the preplate populate the 
cortical plate and become the deepest layer, layer VI, of the cortex (blue circles).  Newly 
generated neurons migrate past the SP and layer VI to populate the outermost layer of the 
CP) and become layer V (red).  Subsequent neuronal generation by radial glia and 
intermediate progenitor cells (IPCs) form the remaining layers of the cortex in an inside-out 
fashion (remaining colored circles).  At late embryonic stages, the radial glia cells generate 
glial cells and SP degenerates to form the final 6-layered cortex observed in the adult.  
Image adapted from Gupta et al. 2002.    
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Figure 2.2 Neuronal Migration in the developing cortex
(A) Pyramidal Neuron Migration.  In the cortex, radial glia cells retract their apical 
process to somally translocate towards the pial surface and form the preplate (grey radial glia 
cells).  During the neurogenic phase, radial glia (1) asymmetrically divide (2) to produce a 
radial glia cell and  multipolar daughter neuron (3) that migrates to the subventricular zone 
(SVZ).  The newly born neuron will polarize into a bipolar morphology (4) with a leading 
process (LP) and trailing process (TP).  Upon polarization the neuron will begin glial-guided 
migration (4-6) until reaching the outermost layer of the cortical plate.  During migration the 
axon extends from the trailing process (purple process).  Upon migration termination the 
neuron leaves the radial glia scaffold, somally translocates to its final position (7) and the 
leading process becomes the apical dendrite (8) and the axon continues to extent and target.  
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(B) Interneuron Migration.  Interneurons born in the ganglionic emanance  (GE) migrate 
tangentially into the cortex without the glial scaffold.  Interneurons migrate in two streams 
(blue and purple) before diving into the cortical plate to adopt their final positions.
Image adapted from Barnes and Polleux 2009 and Nadarajah and Parnavelas 2002.
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Figure 2.3  Cytoskeletal Organization and Adhesion for Migration 
(A)  Microtubule rearrangement during migration and maturation.  (1) multipolar neurons 
sense the environment with plus-end microtubules oriented distally (green arrows).  (2)  
Migrating neurons orient plus-end microtubules distally in the leading process (green arrows) 
and both minus-end distal (red arrows) and plus-end distal (green arrows) microtubules in the 
trailing process.  (3)  Developing dendrites increase in minus-end distal (red) microtubules in 
the dendrites while the axon converts to a plus-end distal microtubule network.
(B)  Adhesion requirement for migration.  (1) In order for migration to occur adhesion 
molecules must be inserted into the leading edge for adherence to the radial glia scaffold.  (2)  
Physical movement along the radial scaffold requires removal of adhesions at the rear of the 
cell soma. Stable adhesions provide stable adherence to the scaffold and are subsequently 
removed at the rear of the cell after saltatory migration. 
Figure Adapted from Sakakibara et al. 2013 and Solecki DJ 2012.
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Figure 2.4  Cortical Projections and Laminar Identity 
 Neurons in each area of the cortex express specific markers and project to specific 
targets.  The deepest layer, layer VI (pink/brown) project to the thalamus while layer V 
neurons (yellow/orange) project to the spinal cord.   Upper layer neurons from layers II and 
III (green) project intracortically and through the corpus callosum to contralateral cortical 
targets.  Image adapted from DeBoer et al. 2013.
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 CHAPTER 3: Glycogen Synthase Kinase-3
3.1 Overview
 The literature on cortical neuronal migration and morphogenesis suggests that 
important kinases, like CDK5 and GSK-3, that regulate the functions of microtubule 
associated proteins might have key roles.  Functions of CDK5 related to neuronal migration 
and layer formation in the cortex have been well studied (Ohshima, Gilmore et al. 1999; Xie, 
Sanada et al. 2003; Tanaka, Serneo et al. 2004; Xie, Samuels et al. 2006; Ohshima, Hirasawa 
et al. 2007).  I therefore have focused my thesis on functions of GSK-3.  This chapter 
provides an introduction to GSK-3 signaling.
3.2 Glycogen Synthase Kinase-3 Structure and Function
 
 Glycogen Synthase Kinase 3 (GSK-3) is a serine/threonine kinase that was originally 
identified as a key regulator of glycogen synthase in glycogen metabolism and insulin 
responses (Woodgett  and Cohen 1984).  GSK-3 is highly conserved from the Drosophila 
homologue zeste-white3/shaggy (Bourouis, Moore et al. 1990; Siegfried, Perkins et al. 1990) 
to humans.     Despite it’s name, GSK-3 is now known to be a multifunctional kinase with a 
broad range of targets and a key role in several signaling cascades.
 GSK-3 α and β are ubiquitously expressed and both are highly expressed in the brain 
during development (Woodgett 1990) in both neurons and in glia (Ferrer, Barrachina et al. 
2002; Kaidanovich-Beilin and Woodgett 2011).  In mammals, GSK-3 has two isoforms, 
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GSK-3α and GSK-3β (Woodgett 1990) that are 85% identical and have a catalytic domain 
similarity of over 90% (Ali, Hoeflich et al. 2001; Kaidanovich-Beilin and Woodgett 2011). 
The main differences between isoforms lie outside the catalytic domain in the N-terminus, 
where the α isoform has an N-terminal extension that may regulate nuclear transport 
(Azoulay-Alfaguter, Yaffe et al. 2011).  Mice and humans have an alternatively spliced 
variant of GSK-3β of unknown function that contains a 13 amino acid inserted sequence in 
the kinase domain and is highly expressed in the nervous system (Mukai, Ishiguro et al. 
2002).  
 Differences in isoform function are evident in mouse models where GSK-3α knockout 
mice are viable (MacAulay, Doble et al. 2007) while GSK-3β knockouts are embryonic lethal 
(Hoeflich, Luo et al. 2000).  These results suggest that in many  cell types GSK-3β is the 
more important family member.  However, we have found that one isoform can clearly 
compensate for the other and that deletion of both isoforms is required to get a full picture of 
GSK-3 function in vivo (Kim, Zhou et al. 2006; Kim, Wang et al. 2009).  In the work 
presented in this thesis both isoforms of GSK-3 have been deleted in neurons of the 
developing dorsal telencephalon. 
3.2.1 GSK-3 Signaling Downstream of RTKs
  GSK-3 has high basal activity towards many of its substrates in resting cells and inhibits 
their function at baseline (Hughes, Nikolakaki et  al. 1993; Kaidanovich-Beilin and Woodgett 
2011).  Unlike most kinases, GSK-3 is inhibited by several upstream signaling pathways, 
transiently  relieving phosphorylation of its substrates and enhancing their function (Hur and 
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Zhou 2010).  GSK-3 is inactivated when phosphorylated on N-terminal Serine 9 (ser9) of 
GSK-3β (Sutherland, Leighton et al. 1993; Stambolic and Woodgett 1994) and Serine 21 
(ser21) of GSK-3α (Sutherland and Cohen 1994).  These phosphorylation events are typically 
mediated by Akt, downstream of receptor tyrosine kinase(RTK)/Phosphoinositide 3-kinase 
(PI3K) signaling.  EGF, PDGF, neurotrophins, IGF and Insulin activate RTKs that, in turn, 
activate PI3K and Akt culminating in ser9/21 GSK-3 phosphorylation (Cross, Alessi et al. 
1995; Kaidanovich-Beilin and Woodgett  2011) [Figure 3.1].  Additionally, signals 
transduced from the RTKs to PAR-6/PAR-3/aPKC can also inactivate GSK-3 kinase activity 
(Etienne-Manneville and Hall 2003).  N-terminal Ser9/21 phosphorylation has been used in 
vitro studies to determine the level of GSK-3 kinase activity  in multiple pathways and cell 
types.  It should be noted that these residues may  not be a correct readout of kinase activity  in 
all signaling paradigms (see below).  Making the situation more complicated, GSK-3 can be 
activated by the phosphorylation of tyrosine residues, Tyr216 of GSK-3β and Tyr279 of 
GSK-3α (Hughes, Nikolakaki et al. 1993).  
   In general, GSK-3 phosphorylates downstream targets with a Serine/Threonine-X-X-X-
Serine/Threonine motif.  Most of GSK-3 substrates require another phosphorylation event 
near the GSK-3 site (‘priming’), mediated by  a different kinase, for maximal GSK-3 activity 
(Sutherland 2011).  Many GSK-3 priming kinases have been identified including, CK1, CK2, 
JNK, ERK, and PKA (for review see Sutherland C 2011).  Though priming is not absolutely 
required for GSK-3 substrate phosphorylation, priming strongly enhances GSK-3 effect 
(Thomas, Frame et al. 1999).  Of specific interest to this thesis, CDK5 is able to prime and 
enhance GSK-3 phosphorylation of MAPS and will be a point of discussion in Chapter 7.  
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3.2.2 GSK-3 Signaling in the Wnt pathway
  Importantly, the Drosophila GSK-3 homologue, Shaggy/zeste white 3, was identified 
in the context of Wnt rather than RTK signaling.  In contrast to RTK signaling where GSK-3 
is regulated primarily via phosphorylation, GSK-3 regulation via Wnt is based on protein-
protein interactions mediated by Disheveled (van Noort, Meeldijk et al. 2002; Doble and 
Woodgett 2003). Again, GSK-3 is active at baseline, phosphorylating and inactivating β-
catenin, and GSK-3 activity  towards this substrate is transiently released when Wnt signaling 
is activated (see below). 
 The Wnt/β-catenin Signaling Pathway is crucial for embryonic patterning, cell fate 
determination, polarity and proliferation (Logan and Nusse 2004).  Wnts (wingless in 
Drosophila) are secreted glycoproteins that bind to the Frizzled-LRP5/6 receptors and act via 
Dishevelled (Dvl) and GSK-3 signaling (For review see Logan and Nusse 2004).  At basal 
levels GSK-3 is sequestered by the scaffolding protein Axin (Ikeda, Kishida et al. 1998; 
Yasuda, Whitmarsh et al. 1999) into a destruction complex that includes the tumor suppressor 
Adenomatous polyposis coli (APC), the GSK-3 priming kinase, casein kinase 1 (CK1)(Amit, 
Hatzubai et al. 2002), and β-catenin (Rubinfeld, Souza et al. 1993).  In this complex GSK-3 
phosphorylates β-catenin on N-terminal residues Thr41, Ser37, and Ser33 (Liu, Li et  al. 
2002).  Phosphorylation of cytoplasmic β-catenin on these residues signal for its degradation 
via the proteosomal pathway (Liu, Kato et al. 1999) [Figure 2.1].  
   The exact mechanism for Wnt-induced inactivation of GSK-3 is still under intensive 
investigation.  Upon Wnt stimulation of Frizzled-LRP5/6, Dvl removes GSK-3 from the 
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destruction complex, probably by protein-protein interaction, and mediates GSK-3 
phosphorylation of the accessory Wnt receptor LRP5/6 (Zeng, Tamai et al. 2005; Dale 2006). 
The disruption of the destruction complex results in the accumulation of non-phosphorylated 
β-catenin and its subsequent translocation to the nucleus (van Noort, Meeldijk et al. 2002). 
Nuclear β-catenin binds to T-cell Factor (TCF)/lymphoid enhancer factor (LEF) transcription 
factors (Behrens, von Kries et al. 1996; van de Wetering, Cavallo et  al. 1997) [Figure 3.1]. 
In general, GSK-3 deletion strongly  enhances β-catenin accumulation and signaling 
(Kaidanovich-Beilin and Woodgett 2011), however this predication has not been carefully 
assessed in all cell types.  GSK-3’s role in Wnt/β-catenin signaling in developing cortical 
neurons is addressed in Chapter 5. 
 GSK-3 activity usually  inhibits substrate functions.  For example, GSK-3 
phosphorylation of β-catenin, cyclin D1 and c-myc targets these proteins for degradation, 
while inhibition of GSK-3 promotes their stabilization and function (Diehl, Cheng et al. 
1998; Alt, Cleveland et al. 2000; Sears, Nuckolls et al. 2000).  Additionally, phosphorylation 
of some microtubule associated proteins (MAPs) inhibit tubulin binding [Figure 3.1].  For 
example, GSK-3 phosphorylation of tau decreases its affinity  for microtubules (Lindwall and 
Cole 1984; Drechsel, Hyman et al. 1992; Hanger, Hughes et  al. 1992; Brownlees, Irving et al. 
1997; Utton, Vandecandelaere et al. 1997).  Similarly, GSK3 phosphorylation of APC 
(Rubinfeld, Albert et al. 1996; Etienne-Manneville and Hall 2003) and CRMP-2 (Inagaki, 
Chihara et al. 2001; Fukata, Itoh et al. 2002; Yoshimura, Kawano et al. 2005) decrease their 
association with microtubules.  Obviously, changes in microtubule binding properties will 
alter cytoskeletal dynamics.
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 However, the situation is complex in that GSK-3 phosphorylation of MAP-1B increases 
its association with microtubules (Lucas, Goold et al. 1998).  Further, GSK-3 activity is 
required for the activity  of some of its substrates, including doublecortin and CRMP-2 
downstream of semaphorin signaling.  I will address several of these GSK-3 substrates in 
Chapter 5.
3.2.3 GSK-3 signaling in the semaphorin pathway
 Though originally identified as axonal repellants (Luo, Raible et  al. 1993), semaphorins 
are diffusible guidance cues that can be both chemoattractive and repulsive (Pasterkamp 
2012).  In the cortex, axons are chemorepulsed by the sema signal and, as a result, project 
their axons away  from the sema gradient (Chedotal, Del Rio et al. 1998; Montolio, 
Messeguer et al. 2009) and limit branching (Dent, Barnes et al. 2004).  In addition, sema 
signaling is also used to mediate axon-axon interaction and by balancing repulsion with 
adhesion/fasiculation is involved with axon defasiculation and targeting (Vactor, Sink et al. 
1993; Pasterkamp 2012).  In the opposite direction, semaphorin 3A-neuropilin-1 signaling is 
a chemoattractive cue that orients the apical dendrite to the pial surface (Polleux, Morrow et 
al. 2000) [Figure 3.2].  Elevating cGMP levels relieves the inhibitory  phosphorylation of 
GSK-3 resulting in increased signaling to substrates and subsequent dendrite orientation.
  Increasing evidence suggests that an increase GSK-3 kinase activity is an essential 
mediator of sema signaling (Eickholt, Walsh et  al. 2002; Uchida, Ohshima et al. 2005; 
Pasterkamp 2012).  Indeed a key  GSK-3 target, collapsing response mediator protein-2 
(CRMP-2) was discovered as downstream of of semaphorin signaling (Uchida, Ohshima et 
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al. 2005). CRMP-2 is a microtubule associated protein whose phosphorylation by  GSK-3 at 
site Thr514 required for cytoskeletal rearrangements that are an essential to semaphorin 
biological actions (Yoshimura, Kawano et al. 2005) [Figure 3.2].  
 Semaphorin signaling via GSK-3 as been implicated in axon and dendrite specification of 
hippocampal and cortical neurons (Tran, Kolodkin et  al. 2007; Shelly, Cancedda et al. 2011) 
In non-polarized neurons a strong dendrite-specifying semaphorin gradient asymmetrically 
increases cGMP levels, increasing GSK-3 signaling, and decreasing the phosphorylation of 
LKB1 on ser431, the residue responsible for specifying the axon (Polleux, Morrow et al. 
2000; Shelly, Cancedda et al. 2011; Shelly and Poo 2011; Pasterkamp 2012) [Figure 3.2]. 
This signaling cascade specifies dendrite identity, suppresses axon formation and promotes 
dendritic growth.  In the opposite direction, pser431 LKB1 (Barnes, Lilley  et  al. 2007; 
Shelly, Cancedda et al. 2007) and an inactive pool of GSK-3 becomes asymmetrically 
localized in the neurite being specified as the axon (Jiang, Guo et  al. 2005) (see below). 
After the axon is initiated, semaphorin 3A treatment rapidly activates the GSK-3 pool in the 
growth cone to facilitate axon repulsion from the semaphorin gradient (Eickholt, Walsh et al. 
2002; Montolio, Messeguer et al. 2009).  
 These actions of GSK-3 in the semaphorin signaling cascade may have strong 
relevance to GSK-3 regulation of excitatory neuron morphogenesis as outlined in my soon to 
be submitted manuscript (Chapter 5).
27
3.3 GSK-3 regulation of polarity; Problems with in Vitro Models
 As noted above, after a neuron is born it polarizes to form an axon and a somatodendritic 
domain and subsequently dendritic processes are elaborated.  This process is highly regulated 
and has been mostly delineated through in vitro hippocampal culture models (Dotti, Sullivan 
et al. 1988; Craig and Banker 1994).  Multiple proteins have been implicated as essential 
components of the polarity cascade (Polleux and Snider 2010).  These include PI3K 
(Menager, Arimura et al. 2004), Akt (Yan, Guo et al. 2006), PTEN (Jiang, Guo et al. 2005), 
CRMP2 (Inagaki, Chihara et al. 2001; Arimura, Menager et al. 2004),  LKB1 (Barnes, Lilley 
et al. 2007; Shelly and Poo 2011) and GSK-3 (Jiang, Guo et al. 2005; Yoshimura, Kawano et 
al. 2005; Yoshimura, Arimura et al. 2006).  
 In vitro experiments suggest a strong role for GSK-3 in regulating neuronal polarity 
(Kim, Hur et al. 2011).  Inactivation of GSK-3 by  Ser9 phosphorylation is essential in 
transitioning the immature neurite into an axon, while pharmacological inhibition of GSK-3 
in vitro leads to multiple axons per individual neuron (Jiang, Guo et al. 2005).  In contrast, 
expression of a S9A mutant GSK-3 prevents axon formation (Jiang, Guo et al. 2005; 
Yoshimura, Kawano et al. 2005).  Inhibition of GSK-3 and relief of phosphorylation of 
microtubule associated proteins is thought to enhance microtubule stability, which is 
important in specifying an axon (Witte, Neukirchen et al. 2008) (for review see Stiess and 
Bradke 2010).
 In an effort to address the role of ser9/21 in an in vivo environment, GSK-3 point 
mutation knock-in mice have been created.  Mutant mice expressing GSK-3 with Ser9/21 
converted to alanine create, in theory, a ‘constitutively  active’ GSK-3.  Thus, these mutations 
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should result in steady basal activation of GSK-3 and excessive and uncontrolled 
phosphorylation of downstream targets.  However, these animals exhibit normal neuronal 
polarity and develop with no overt abnormalities of neuronal morphology  (McManus, 
Sakamoto et al. 2005; Gartner, Huang et al. 2006).  These results raise the possibility  that 
ser9/21 phosphorylation may not be important to the morphological regulation of neurons in 
vivo.  The dramatic difference between in vitro and in vivo GSK-3 phenotypes strongly 
supports the need to study  the role of GSK-3 in a natural in vivo environment.  My thesis 
directly addresses the role of GSK-3 in neuronal morphogenesis in vivo (Chapter 5).  
3.4  GSK-3 Functions in vivo in Progenitors
 GSK-3 signaling is known to be essential for the regulation of progenitor proliferation 
in the developing dorsal telencephalon in vivo.  Kim et al. convincingly showed that deletion 
of both GSK-3 isoforms in the cortical radial progenitors resulted in an expansion of the 
progenitor pool and suppressed neuronal differentiation (Kim, Wang et al. 2009) [Figure 
3.3].  Wnt, Sonic hedgehog (Shh) and Notch signaling were all implicated as enhanced by 
GSK-3 deletion.  Kim and colleagues observed a strong increase in β-catenin levels in the 
GSK-3 deleted cells demonstrating GSK-3 regulation of β-catenin is essential for progenitor 
homeostasis.  Consistent with these results, Walsh and colleagues have shown that increasing 
β-catenin levels in progenitors increases the production of neural precursors (Chenn and 
Walsh 2002).  Importantly, the schizophrenia-associated protein, DISC1, is thought to act in 
part by regulating neural progenitor proliferation via GSK-3 (Mao, Ge et al. 2009).  Recently, 
work from the Ip lab has demonstrated a novel role for GSK-3 IPC amplification via the 
destruction complex mediator, Axin (Fang, Chen et al. 2013).  Axin amplifies IPC conversion 
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to neurons and was shown to bind GSK-3 as a part of its actions.  Taken together, these 
studies establish critical roles for GSK-3 in the regulation of progenitors in the developing 
dorsal telencephalon in vivo and suggest that GSK-3 signaling importantly controls neuronal 
number in the developing brain.  However, functions of GSK-3 in developing neurons in vivo 
remain elusive and form the subject of my thesis work (Chapter 5).
3.5  GSK-3 Function in Mature Neurons and Human Diseases
 Not surprisingly, GSK-3 exhibits important functions in mature neurons.  For the most 
part this regulation has been studied in in vitro models.  For example, pharmacological 
inhibition of GSK-3 decreases vesicular transport in axons by  reducing tau phosphorylation 
and binding to the motor protein kinesin-1 (Cuchillo-Ibanez, Seereeram et al. 2008). 
Additionally, GSK-3 phosphorylates Dynamin 1 (Clayton, Sue et al. 2010) to regulate bulk 
endocytosis during periods of high activity when clatherin-dependent endocytosis is unable 
to endocytose large amounts of membrane.  Finally, it has been demonstrated that GSK-3 is 
essential for LTD and over expression blocks LTP (Hooper, Markevich et  al. 2007; Peineau, 
Taghibiglou et al. 2007; Zhu, Wang et al. 2007), possibly through PSD-95 regulation 
(Nelson, Kim et al. 2013).  Though this thesis will not address the role of GSK-3 in mature 
neurons, this topic will be discussed in Chapter 6.
  GSK-3 has important functions in psychiatric and neurologic diseases making further 
understanding of its role in neural development an urgent priority.  For example, abnormal 
GSK-3 activity  may underlie mood disorders.  Thus Lithium, a known GSK-3β inhibitor, is 
the mainstay of treatment for bipolar disorder (Klein and Melton 1996; O'Brien, Harper et al. 
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2004)(Stambolic, Ruel et al. 1996; De Sarno, Li et al. 2002; Freland and Beaulieu 2012). 
Additionally, the drug valproate, also sometimes used to treat mood disorders, is also an 
inhibitor of GSK-3 kinase activity (Chen, Huang et al. 1999; De Sarno, Li et al. 2002).  
 GSK-3 may also be important in the pathogenesis of schizophrenia (Emamian 2012). 
Administration of antipsychotics, haloperidol or clozapine inhibits GSK-3 activity via ser9 
phosphorylation (Emamian, Hall et al. 2004; Emamian 2012).  Additionally, a regulator of 
GSK-3, Disrupted-in-Schizophrenia 1 (DISC1) has been implicated as a major susceptibility 
factor for Schizophrenia (De Rienzo, Bishop et al. 2011).  DISC1 functions in party  by 
affecting the GSK-3 functions related to progenitor proliferation in both neonates and adults 
(Mao, Ge et al. 2009).  
 Finally in Alzheimer’s disease, two of the hallmarks of the disease are aggregation of 
amyloid-β peptides from amyloid precursor protein and the development of neurofibrially 
tangles composed of hyper-phosphorylated tau (Glenner and Wong 1984).  Interestingly 
GSK-3 inhibition blocks the production of amyloid-β peptides suggesting that GSK-3 is 
required for normal amyloid precursor protein function (Phiel, Wilson et al. 2003). 
Additionally, GSK-3 strongly regulates the phosphorylation status of the MAP tau (Ishiguro, 
Shiratsuchi et al. 1993) (see above).  Hyper-phosphorylated tau is found in the neurofibrially 
tangles in the brains of Alzheimer’s patients (Hanger, Hughes et al. 1992; Pei, Braak et al. 
1999; Lucas, Hernandez et  al. 2001).  Hyper-phosphorylated tau also underlies a class of 
neurodegenerative diseases called tauopathies.  
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 Although my dissertation does not address the functions of GSK-3 in adult neurons, 
better understanding of GSK-3 regulation during neuronal development, including the 
regulation of microtubule associated proteins, may inform approaches to inhibiting GSK-3 
for therapeutic intervention.  
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3.6 FIGURES AND FIGURE LEGENDS
Figure 3.1 GSK-3 Signaling Cascades
(A-B) Canonical Wnt Signaling.  (A) At basal levels GSK-3 is associated with casein kinase, 
APC, Axin and β-catenin in a ‘destruction‘ complex.  GSK-3 phosphorylates β-catenin to 
signal its degradation.  (B) Upon Wnt stimulation GSK-3 is sequestered away from the 
destruction complex leading to the accumulation of β-catenin and altered gene expression.  
(C) Receptor Tyrosine Kinase Signaling.  GSK-3 is downstream of multiple cascades.  
Signaling through PI3K/AKT leads to ser9 phosphorylation or GSK-3 and GSK-3 inhibition.  
GSK-3 signals to multiple downstream Microtubule Associated Proteins (MAPS).   
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Figure 3.2  Semaphorin signaling in dendrite development
 (A) Schematic of semaphorin gradient specifying dendrite formation.  (B) A strong 
semaphorin signal asymmetrically increases cGMP levels to specify dendrite identity.  
Increased cGMP in the dendrites decreases the phosphorylation of STK11 (LKB1) and 
GSK-3, increasing GSK-3 signaling in the dendrite.   Both Ser431 phosphorylation of LKB1 
and GSK-3 inactivation in a single neurite are required initiating an axon.  Figure adapted 
from Pasterkamp 2012. 
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Figure 3.3  GSK-3 regulation of Progenitor Homeostasis
 (A-A’) Coronal sections of E13.5 control and GSK-3 deleted mice.  GSK-3 mutants have an 
increased progenitor pool (sox2).  Nestin labels Radial Glia. Scale 900uM.   (B-B’) Coronal 
sections of E13.5 control and GSK- 3 deleted mice.  GSK-3 mutants have fewer Tuj1-labeled 
neurons and increased progenitor pool (Sox2). Scale bar = 500uM.  Figure adapted from Kim 
et al.  Nat. Neuroscience 2009
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CHAPTER 4: TGF-β Activated Kinase 1
 
4.1 Overview 
 Neurons are some of the most highly polarized cells in the body and the polarization 
of axons and dendrites underlies the proper flow of information in the brain.  Currently, the 
molecular mechanisms responsible for neuronal polarization during brain development in 
vivo are unclear.  However, recent work from several labs have started to defined a signaling 
cascade required for cortical neuron polarization in vivo.  At the core of this cascade is the 
phosphorylation of a serine/threonine kinase, LKB1, on its serine residue 431.  Here I 
demonstrate in vitro that TGF-β Activated Kinase-1 (TAK1) is capable of associating with 
LKB1 and phosphorylating LKB1 on serine 431.  Additionally, in vitro knock-down of TAK1 
in dissociated cortical cultures results in delayed polarization, consistent with a role in axon 
formation.  Finally, genetic deletion of TAK1 in progenitors resulted in no overt change in 
lamination or polarization in vivo.  Despite promising in vitro data, our results indicate that 
TAK1 is not the major upstream kinase responsible for transducing the polarization cascade 
in vivo.
 The work in this chapter was conducted under the direction of Franck Polleux, PhD.  
Following the completion of the TGF-β Activated Kinase-1 project I generated LKB1:Nex 
conditional mutants and conducted initial characterization on this mutant line (data not 
shown).  This work was continued by Dr. Polleux at Scripps and was recently published 
(Courchet, Lewis et al. 2013).
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4.2 Introduction
 Following cell cycle exit, neurons polarize by undergoing drastic morphological changes 
to form two distinct domains: a single axon and multiple dendrites.  While many proteins 
have been implicated in the establishment of neuronal polarity  and axon specification in 
vitro, such as APC (Shi, Cheng et al. 2004), PI3K (Yoshimura, Arimura et al. 2006), and 
GSK-3 (Shi, Cheng et al. 2004; Jiang, Guo et al. 2005; Yoshimura, Kawano et al. 2005), few 
of these genes have been shown to be required for neuronal polarization in vivo.  However, 
recent work demonstrated that LKB1, the ortholog of Caenorhabditis elegans Partitioning-
defective 4 (Par4 or STK11), is critical for the establishment of neuronal polarity  in vivo 
(Kishi, Pan et al. 2005; Barnes, Lilley et al. 2007; Shelly, Cancedda et al. 2007; Shelly  and 
Poo 2011). 
 The vast  majority of LKB1 protein is inactive and located in the nucleus with STRADβ 
(Dorfman and Macara 2008).  Upon a polarization cue, LKB1 is shuttled into the cytosol by 
STRADα and MO25 and this translocation increases the catalytic activity of LKB1 by 
approximately 10-fold (Baas, Boudeau et al. 2003).  In epithelial cells, activation of LKB1 
via an inducible STRADα was sufficient to induce polarity  (Baas, Kuipers et  al. 2004) 
indicating a critical role for LKB1 in this process.  As in epithelial cells, the translocation of 
LKB1 to the cytoplasm in cortical neurons allows for LKB1 to be activated by 
phosphorylation of an axon-specifying residue, serine 431 (Barnes, Lilley et al. 2007).  This 
phosphorylation event leads to pLKB1 being sequestered to the a single neurite, 
phosphorylation of downstream SAD kinases and finally, axon initiation (Barnes, Lilley et al. 
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2007; Shelly, Cancedda et  al. 2007).  The kinase upstream of the LKB1 phosphorylation of 
ser431 is unknown.  Recently, the Schneider lab demonstrated that the kinase TAK1 is 
capable of phosphorylating and inducing LKB1 activity in vivo (Xie, Zhang et al. 2006) 
suggesting that TAK1 could be acting upstream of LKB1 in the polarization cascade.    
 TGF-β activated kinase 1 (TAK1) is a serine/threonine kinase initially identified as a 
mitogen-activated protein kinase (Yamaguchi, Shirakabe et  al. 1995).  While it can be 
activated by TGF-β, TAK1 has been implicated in both the JNK (Shirakabe, Yamaguchi et al. 
1997; Wang, Zhou et al. 1997) and P38 MAPK pathways (Moriguchi, Kuroyanagi et al. 
1996) and has critical roles in cell survival, proliferation, stress response and immune 
regulation (Delaney and Mlodzik 2006).  Interestingly, the role of TAK1 has not been 
assessed in cortical neurons.    
 TAK1 requires a combination of adaptor proteins, TAK1 Binding proteins 1, 2 and 3 
(TAB1, TAB2 and TAB3), for its activation (Shibuya, Yamaguchi et al. 1996; Kishimoto, 
Matsumoto et al. 2000; Takaesu, Kishida et al. 2000).  While TAK1 association with either 
TAB2 or TAB3 associates the complex to specific receptors, K63-linked ubiquitination along 
with TAB1 physical association enable TAK1 kinase activity (Shibuya, Yamaguchi et al. 
1996; Kishimoto, Matsumoto et al. 2000; Sakurai, Miyoshi et al. 2000; Takaesu, Kishida et 
al. 2000; Landstrom 2010).  Of particular note, TAK1 knockout mice are embryonic lethal 
(Sato, Sanjo et al. 2005) and therefore the majority  of the studies related to TAK1 have been 
conducted  in vitro.  
 Here I have addressed the function of TAK1 in neuronal polarity  both in vitro and in vivo 
using Emx1-Cre (Gorski, Talley et  al. 2002) and a conditional TAK1loxp/loxp mouse (Sato, 
38
Sanjo et al. 2005).  I demonstrate in vitro that TAK-1 is capable of associating with LKB1 
and phosphorylating LKB1 on ser431.  The phosphorylation of LKB1 is enhanced by  TAB1 
co-expression.  Additionally, overexpression of TAK1 in newly born neurons results in a 
delay in axon initiation in vitro, consistent with a role for TAK1 in polarization upstream of 
LKB1.  Finally, deletion of TAK1 in vivo does not inhibit axon initiation, as seen with LKB1 
deletion with Emx1-cre (Barnes, Lilley et  al. 2007).  We conclude that in vivo TAK1 is not a 
critical regulator of polarity in newly born neurons of the developing dorsal telencephalon.
4.3 Results
TAK1 expression in the developing murine cortex
 In vivo deletion of LKB1 in cortical pyramidal neurons results in a loss of axon formation 
(Barnes, Lilley et  al. 2007) [Figure 4.1].  Furthermore, re-expression of LKB1 via cortical 
electroporation of the conditional LKB1 knockout neurons was able to rescue axon formation 
[Figure 4.1].  Interestingly, Barnes et  al. identified a residue in LKB1, serine 431, that 
specifies axon formation.  A mutation in LKB1, serine 431 to alanine mutation (LKB1S431A), 
was not able to rescue axon formation [Figure 4.1].  These data indicate the in vivo 
importance of LKB1, specifically the phosphorylation of LKB1 on serine 431, in neuronal 
polarization (Barnes, Lilley et al. 2007).
 Recently, TAK1 expression has been shown to regulate LKB1 kinase activity (Xie, Zhang 
et al. 2006) making it  an upstream candidate for LKB1 phosphorylation.  However, the role 
of TAK1 in the developing cortex has never been explored.  LKB1 is expressed throughout 
the cortex but is enriched in the progenitor zone (VZ) of the developing cortex [Figure 
4.2A].  Similar to LKB1, TAK1 is highly also highly expressed in the ventricular zone of the 
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developing cortex at E14 [Figure 4.2A] suggesting a role in early  neuronal regulation. 
Additionally, the adaptor protein TAB2 also shares the same expression profile [Figure 4.2A] 
suggesting that the TAK1 activating complex is expressed in the VZ of the developing 
cortex.  To date no information on TAB1 or TAB3 expression is currently available.  These 
data suggest that TAK1 is located in at right place and time in vivo to regulate neuronal 
polarization in the developing cortex.  
TAK1 phosphorylates LKB1 in HeLa cells
 In order to ascertain the role of TAK1-LKB1 signaling in cortical development I sub-
cloned TAK1 and its activator, TAB1, and expressed these two proteins in conjunction with 
LKB1 in HeLa.  HeLa cells lack endogenous TAK1, TAB1 and LKB1 expression.  Lysates 
from these transfections were probed with an antibody specifically  recognizing 
phosphorylated serine 431 on LKB1.  Interestingly, TAK1 is capable of inducing 
phosphorylation of LKB1 on serine 431 [Figure 4.2B] in the presence or absence of TAB1 
transfection.  However, the degree of LKB1 phosphorylation is greatly  increased with the co-
transfection of TAB1, demonstrating the importance of TAB1 for TAK1 function [Figure 
4.2B].  These results were further supported in vitro by the transfection of the LKB1S431A 
mutant in conjunction with TAK1 and TAB1.  This LKB1 mutant is not able to be 
phosphorylated by the addition of TAK1 and TAB1, providing specificity to the biochemical 
detection of phosphorylated serine 431 [Figure 4.2B].  Finally, transfection of HeLa cells 
with LKB1, TAB1 and a kinase dead form of TAK1 (KD-TAK1) also failed to phosphorylate 
LKB1 on serine 431 [Figure 4.2B].  Successful expression of TAK1, TAB1 and LKB1 was 
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verified via western blot analysis [Supplemental Figure 4.1].  These data indicate that in 
vitro, TAK1 is capable of phosphorylating LKB1 on the residue responsible for axon 
formation, serine 431.
TAK1-LKB1 interact in vitro  
 TAK1 is capable of phosphorylating LKB1 in vitro suggesting that  TAK1 and LKB1 
physically associate in vitro.  To test this hypothesis I transfected HEK293 cells with 
combinations of LKB1, TAK1 and TAB1 and subjected these lysates to co-
immunoprecipitation using an LKB1-specific antibody [Figure 4.3A, circled area]. 
Interestingly, TAK1 and LKB1 associate in every transfection combination that included 
TAK1 and LKB1 (data not shown).  This association occurred regardless of TAB1 
transfection, indicating that TAB1 is not responsible for the TAK1-LKB1 interaction and that 
TAK1 and LKB1 may directly associate.
 Interestingly, though LKB1 association with TAK1 was present in all transfections 
including the two constructs, the amount of TAK1 associated with LKB1 was minimal 
[Figure 4.3A, circled area].  One explanation is that the majority of LKB1 is located in the 
nucleus, while TAK1 is predominantly located in the cytosol (Baas, Boudeau et al. 2003).  To 
address this issue I conducted a second co-immunoprecipitation experiment and pulled down 
for TAK1 in the cytosol and then probed for LKB1 association [Figure 4.3 B].  Indeed, a 
large amount of cytosolic LKB1 was associated with TAK1, indicating that these two kinases 
interact in vitro.
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TAK1 expression in cortical neurons  
 Phosphorylation of LKB1 on serine 431 enriches LKB1 in the axon (Barnes, Lilley et  al. 
2007).     Therefore we hypothesized that  TAK1 may also be preferentially localized to the 
developing axon.  To address the neuronal localization of TAK1, E14.5 cortical neurons were 
cultured for 3 days and then stained for TAK1 expression.  Interestingly, TAK1 is 
ubiquitously expressed in cortical neurons and appears enriched in the growing axon [Figure 
4.4A].   Given that serine 431 phosphorylation of LKB1 is essential for axon formation, 
we hypothesized that overexpression of TAK1 would inhibit axon initiation due to 
mislocalization of TAK1 protein in the cell.  Interestingly, overexpression of TAK1 in this 
paradigm resulted in a multiple short neurites and the absence of a single long axon after 
three days of culture [Figure 4.4B] while control cultures imaged at two and three days in 
vitro depict a normal stage progression in culture [Figure 4.4C].  In control neurons at 3DIV 
approximately sixty percent of control neurons have progressed to a stage 3 (i.e. have a 
polarized morphology with a single axon).  However, only approximately twenty-six percent 
of TAK1 overexpressing neurons have progressed to stage 3 indicating that TAK1 may 
regulate neuronal polarization in vitro.  A similar phenotype is observed by over-activation of 
LKB1 (Barnes, Lilley et al. 2007; Shelly, Cancedda et al. 2007) suggesting that these two 
kinases might be in the same pathway. 
TAK1 is Not Required for Polarization in vivo 
  To confirm that TAK1 is required for LKB1-mediated neuronal polarization in vivo, I 
generated a cortex-specific conditional knockout for TAK1 by breeding a TAK1loxp/loxp mouse 
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(Sato, Sanjo et al. 2005) conditional mouse to Emx1-Cre (Gorski, Talley et al. 2002).  This 
conditionally deletes TAK1 in the progenitors of the cortex beginning around E10.5.  Similar 
to LKB1:Emx mutants, the TAK1:Emx mutant mice die at birth due to unknown causes. 
 Western blot analysis from cortical lysates show a significant reduction in TAK1 
protein by E16.5 in TAK1:Emx mutants when compared to littermate controls [Figure 4.5 
E].  Interestingly, though not unexpected, no change in LKB1 protein was observed in 
TAK1:Emx mutants.  Surprisingly, no change in pser431 LKB1 was observed in the mutants 
[Figure 4.5 E], suggesting that loss of TAK1 in the developing neocortex does not alter the 
axon-specific phosphorylation of LKB1 on serine 431. Further in vivo analysis of the 
TAK1:Emx mutant embryos showed no defect in cortical lamination (data not shown).
 Previous work from the Polleux lab showed that loss of LKB1 resulted in drastically 
reduced TAG1+ corticofugal axon projections (Barnes, Lilley et al. 2007) [Figure 4.5 A-B].  
In line with no change in serine 431 phosphorylation of LKB1, TAK1:Emx mutants did not 
recapitulate this phenotype [Figure 4.5 C-D].  Taken together these data indicate that TAK1 
is not required upstream of LKB1 for axon formation in vivo.  
4.4 Discussion
 Phosphorylation of LKB1 on serine 431 is critical for cortical neuronal polarization 
(Barnes, Lilley  et al. 2007; Shelly, Cancedda et al. 2007) however the kinase responsible for 
this phosphorylation event in vivo has not been identified.  TAK1, a kinase with critical 
functions in innate and adaptive immune response, was found to phosphorylate LKB1 and 
induce its kinase activity  (Xie, Zhang et  al. 2006).  I have found that TAK1 phosphorylates 
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the LKB1 axon-specifying residue ser431 and physically associates LKB1 in HEK293 and 
Hela cells in vitro.   Promisingly, overexpression of TAK1 delayed polarization suggesting 
a role in axon initiation similar to LKB1.  However, TAK1 requires TAB1 for kinase activity 
and therefore overexpression of TAK1 does not directly relate to TAK1 kinase activity 
towards its substrates.  Instead, overexpression could act as a dominant negative due to 
limited amounts of TAB1 in the cell.  Interestingly, Overexpresion of both TAK1 and TAB1 
results in rapid cell death by 1 DIV therefore quantitative analysis could not be conducted 
(data not shown).  
 Genetic deletion of TAK1 revealed no change in cortical lamination (data not shown) and 
TAK1:Emx mutants were able to project axons at late embryonic stages.  These data suggest 
that TAK1 is (1) not the major kinase upstream of LKB1 or (2) a compensatory  signaling 
cascade is able to phosphorylate LKB1 to initiate polarization.  Recently, TAK1 and TAB1 
were shown to phosphorylate SAD kinases downstream of LKB1, further suggesting a role in 
polarization (Lilley, Pan et al. 2013).  However, deletion of TAK1 using Nestin-cre and Islet 
cre did not alter polarization in vivo and double mutants for TAK1 and LKB1 did not 
enhance any effect of on the downstream SAD kinases in vivo (Lilley, Pan et al. 2013).  
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Future Directions
 Though TAK1 was a promising candidate for neuronal polarization in vitro no phenotype 
was observed in vivo.  Interestingly, TAK1-TAB1 overexpression results in enhanced cell 
death (data not shown) suggesting a key  role for these proteins in neuronal survival. TA K 1 
is a key kinase in innate and adaptive immunity  and has been studied extensively  in cell 
lines.  However, the role of TAK1 in neurons has never been addressed.  It would be 
interesting to cross the TAK1 mutant with a Bax knockout to analyze cell death regulation as 
well as possible changes in glia formation.
 Upon completion of the TAK1 project I generated LKB1:Nex mutants to define a role for 
LKB1 in axon growth and branching.  I was able to conduct initial characterization of this 
genetic deletion prior to Dr. Franck Polleux’s departure to The Scripps Research Institute. 
Though the role of LKB1 in axon branching was recently published (Courchet, Lewis et al. 
2013), the role of LKB1 in cortical lamination will be addressed in Chapter 5.
4.5 Experimental Procedures
Mice
 Mice were used according to a protocol approved by the Institutional Animal Care 
and Use Committee and The University of North Carolina at Chapel Hill.  Time-pregnant 
females were obtained by overnight breedings with males with 8am as conception.
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Cortical Progenitor Dissociated Cultures
 E14.5 dorsal cortices were electroporated and dissected in 4ºC Hank’s Balanced Salt 
Solution (HBSS; Gibco) and dissociated into single cells using Trypsin (Gibco) according to 
previously described methods (Hand, Bortone et al. 2005). Neurons were plated on glass 
bottom dishes (MatTek) coated with 0.1mg/mL Poly-D-Lysine (Sigma) and 5µg/mL Laminin 
(Sigma). Cells were cultured in Neuralbasal-A Medium (Invitrogen), supplemented with 1X 
B-27 (Gibco), L-glutamine (Gibco), penicillin-streptomycin (Gibco), and N2 (Gemini).  
Neurons were fixed with 4% PFA and stained for stage progression analysis.  All constructs 
were cloned into the pCIG2 vector (Hand, Bortone et al. 2005).  This vector uses a CMV-
enhancer/chicken-beta-actin promoter with and IRES-eGFP.  The TAK1 kinase dead 
construct was created by mutating Lysine 63 to a Tryptophan.  Images were taken using a 
LEICA TCS SL confocal microscope.  Antibodies Used:  Tuj1 (beta-III tubulin)(Sigma), 
TAK1 (Cell Signaling), MAP2 (Sigma), DRAQ5 (Fisher), Tau (Millipore), GFP (Aves).
HEK293 and HELA Cell Cultures and Transfections
 HEK293 and HELA cells were cultured in DMEM with 10% PBS 2mM L-glutamine 
and penicillin/streptomycin supplements.  Cells were transfected using lipofectamine 2000 
(4ul) with 2ug of DNA in Opti-mem media and added to cells for 3-12 hours after which 
media was replaced.  Cells were cultured for 24 hours and lysed using RIPA buffer. 
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Biochemistry
 Mouse cortices were dissected from three control (TAK1loxp/+:Emx) and mutant 
(TAK1:Emx) mice from independent litters, collected in RIPA lysis buffer  (50mM Tris, pH 
7.4, 1% Triton X-100, 0.25% Sodium Deoxycholate, 0.1% SDS, 1mM EDTA, 150mM NaCl) 
supplemented with protease and phosphatase inhibitors and cleared by centrifugation.  
Proteins were separated on SDS-PAGE gradient gels, transferred to a PVDF membrane and 
probed for TAK1 (Cell Signaling), LKB1 (Millipore), pser431 LKB1 (Invitrogen), the 
internal control Actin (Cell Signaling) and secondary HRP-conjugated antibodies for 
detection.  Blots were washed and detection was performed with a commercially available 
ECL kit.  Co-immunoprecipitation experiments were conducted using cell lines lysed with 
Co-IP buffer (50mM Tris-Cl, pH 7.4, 15mM EGTA, 100mM NaCl, 0.1% Triton X-100, 
protease inhibitor, 1mM DTT and 1mM PMSF).  10% of the lysis was collected prior to co-
immunoprecipitation for input controls.  The remaining lysis was subjected to co-
immunoprecipitation using TAK1 C9 (Santa Cruz) or LKB1 D19 (Santa Cruz) and bound to 
protein A/G beads (Santa Cruz).  Samples were washed, centrifuged and the supernatant 
removed and then boiled in SDS loading buffer to obtain the bound fraction.  Samples were 
run according to western blots (above).
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4.6 FIGURES AND FIGURE LEGENDS
Figure 4.1  Phosphorylation of Ser431 on LKB1 is required for axon formation.  
E14.5 LKB1:Emx heterozygous and homozygous embryos were electroporated with GSP, 
LKB1 or LKB1-S431A.  Loss of LKB1 resulted in a decrease in the length of the longest 
neurite i.e. the axon (A).  While this phenotype was fully rescued with wild-type LKB1 
electroporation (B) it was not rescued by LKB1-S431A mutant electroporation.  (Schema 
adapted from Barnes et al. 2007, culture data from Polleux and Barnes, Unpublished)
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Figure 4.2 Cortical TAK1 Expression and Phosphorylation of LKB1 in vitro.
(A)  Cortical Expression of LKB1, TAK1 and TAB2 at Embryonic Day 14.5.  LKB1 
Expression is enriched in the progenitor rich ventricular zone of the developing mouse 
neocortex (indicated by arrow).  Both TAK1 and TAB2 expression are also enriched in the 
ventricular zone of the neocortex.  (Images obtained from genepaint.org)
(B)  TAK1 can phosphorylate LKB1 on Ser431 in vitro.  Hela cells were co-transfected with 
combinations of TAK1, TAB1, LKB1, LKB1-s431A, and a kinase-dead TAK1 (TAK1-
K63W).  Cells were harvested 24 hours post transfection and lysed in RIPA buffer containing 
proteases and phosphatase inhibitors.  A) Lysates were subjected to Western Blot analysis 
and probed for pS431-LKB1 and actin.
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Figure 4.3 TAK1 Physical Association with LKB1 in vitro. 
(A)  TAK1 Physical Association with LKB1 in HEK293 Cells.  Co-transfections of plasmids 
encoding TAK1, TAB1, and LKB1 were co-immuniprecipitated using an LKB1 Antibody 
and probed for TAK1 association.    
(B) HEK293 cells transfected with plasmids encoding TAK1, TAB and LKB1 were co-
immunoprecipitated using a TAK1 antibody and probed for LKB1 association.
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Figure 4.4.  TAK1 expression in cortical neurons.
(A) Endogenous TAK1 expression in E14.5 dissociated cortical neurons.  Neurons were 
stained for TAK1, Tuj1 (neuron-specific tubulin isoform), DRAQ5 (nuclear marker).  
(B) TAK1 overexpression delays neuronal polarization.  TAK1 overexpression at E14.5 
followed by imaging 3 days in vitro.   TAK1 overexpressing neurons have an increased 
multipolar stage and delayed transition into a polarized neuron with a developing axon 
(pCIG2 control). Neurons were stained for GFP, MAP2 (dendritic marker), and Tau1 (axonal 
marker).
(C).  TAK1 overexpression at E14.5 followed by stage progression analysis at 2 and 3 days in 
vitro.  TAK1 overexpression results in an increased multipolar stage at both 2 and 3 days in 
vitro when compared to control.
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Figure 4.5.  TAK1 is not required in vivo for axon formation. 
(A-B) Sections from E15.5 LKB1:Emx control and mutant embryos stained for Tag1 
(corticofugal axon subset).  LKB1:Emx mutants do not produce a Tag1-postive axon.
(C-D) TAK1:Emx control and mutant sections from E15.5 embryos.  Sections were stained 
with DRAQ5 (nuclear marker), CTIP2 (layer IV neurons), and Tag1 (corticofugal axon 
subset).  Both TAK1:Emx control and mutants project axons (arrows).
(E) Western blot analysis of E16.5 TAK1:Emx cortical lysates..  Representative western blot 
shows visual verification of decreased TAK1 expression in TAK1:Emx mutants when 
compared to controls.  Quantification box plot of TAK1 protein expression in mutants and 
controls verifies significant decrease in TAK1 protein while no changes were observed in 
LKB1 and LKB1-s431 expression.
(LKB1 image adapted from Barnes et al. 2007)
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4.7 Supplemental Figures and Figure Legends
Supplemental Figure 4.1  Construct Expression in HeLa Cells
HeLa Cells, which lack endogenous TAK1, TAB1 and LKB1 were transfected with 
combinations of constructs, lysed and probed for expression.  LKB1, TAK1 and TAB1 are all 
expressed in these cells.
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CHAPTER 5:  Functions of GSK-3 Signaling in Developing Cortical Neurons
 
5.1  Overview
 Glycogen synthase kinase 3 (GSK-3) signaling is known to influence neuronal 
number in the developing telencephalon via regulation of radial progenitors and intermediate 
neuronal precursors (INPs).   However functions of GSK-3 related to cortical lamination and 
circuit formation have not been established.  In order to assess GSK-3 functions in 
developing cortical neurons in vivo we created mouse mutants lacking both GSK-3α and 
GSK-3β in newly born cortical excitatory neurons.  GSK-3 deleted neurons expressing upper 
layer markers exhibited striking failure of radial migration in all areas of the developing 
cortex.  Migration failure was cell autonomous and persisted into postnatal life.  In contrast, 
GSK-3 deletion in interneuron populations did not disrupt tangential movement.  Perhaps 
surprisingly, misplaced GSK-3 deleted neurons extended an axon into the corpus callosum, 
elaborated an apical process, and developed dendritic arbors.  However, the apical dendrite 
was frequently branched while the basal dendrites exhibited grossly abnormal orientation.  In 
contrast to the regulation of proliferation in progenitors, GSK-3 regulation of migration in 
neurons appeared to be independent of Wnt/β-catenin signaling.  Importantly, 
phosphorylation of the migration mediator, doublecortin (DCX) at ser327 and 
phosphorylation of the semaphorin signaling mediator, CRMP-2 at Thr514 were significantly 
decreased, potentially accounting for the abnormalities observed.  Our data demonstrate that 
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GSK-3 signaling is essential for radial migration and morphogenesis of cortical excitatory 
neurons in the developing cortex.
5.2 Introduction
 GSK-3 α and β are serine/threonine kinases that act as key downstream regulators in 
multiple signaling pathways, including Wnt/β-catenin, Receptor Tyrosine Kinase (RTK)/
PI3K and Sonic hedgehog (Shh) (Kaidanovich-Beilin, Beaulieu et al. 2012).  GSK-3s act via 
mechanisms that include regulation of transcriptional factors, control of multiple aspects of 
cellular metabolism, and phosphorylation of cytoskeletal proteins (Hur and Zhou 2010; 
Kaidanovich-Beilin and Woodgett 2011). Most often, although not invariably, GSK-3s 
function as negatively acting kinases by inhibiting the functions of substrates at baseline.  
Inhibition is then relieved via signaling pathways that engage GSK-3s (Doble and Woodgett 
2003; Kaidanovich-Beilin and Woodgett 2011).  For most GSK-3 substrates, phosphorylation 
by another kinase near the GSK-3 site (‘priming’) is required for, or enhances GSK-3 
substrate phosphorylation (Cohen and Frame 2001; Doble and Woodgett 2003; Kaidanovich-
Beilin and Woodgett 2011).  Priming kinases for GSK-3 substrates include cyclin dependent 
kinase-5 (CDK5), a kinase that is known to regulate important neurodevelopmental events 
like radial migration (Tanaka, Serneo et al. 2004; Cole, Causeret et al. 2006; Li, Hawkes et 
al. 2006; Xie, Samuels et al. 2006).
 In the nervous system GSK-3β has long been thought of as a target of lithium used in 
treatment of bipolar disorder (Klein and Melton 1996; O'Brien, Harper et al. 2004).  Some of 
the GSK-3β effects related to lithium actions are due to regulation of signaling downstream 
of dopamine receptors (Beaulieu, Sotnikova et al. 2004; Beaulieu, Marion et al. 2008; Urs, 
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Snyder et al. 2012).  More recently GSK-3s have been implicated in the pathogenesis of 
schizophrenia (Emamian, Hall et al. 2004; Mao, Ge et al. 2009; Emamian 2012).  Disrupted 
in Schizophrenia-1 (DISC1), mutated in some familial cases of schizophrenia, is thought to 
function in part by modulating GSK-3β effects on progenitor proliferation (Mao, Ge et al. 
2009; Singh, De Rienzo et al. 2011).
 Despite the obvious importance of GSK-3 signaling in pathogenesis and treatment of 
psychiatric disorders, there are important gaps in information on the role of GSK-3 in the 
developing brain.  It has clearly been established that GSK-3 signaling is a strong regulator 
of radial progenitor proliferation in the developing cerebral cortex and that these effects are 
at least partly meditated through β-catenin (Chenn and Walsh 2002; Kim, Wang et al. 2009).  
Additionally, a recent study demonstrated an important role for GSK-3 in regulating INP 
amplification, an effect associated with GSK-3 binding to the scaffolding protein Axin (Fang, 
Chen et al. 2013).  Thus, critical roles for GSK-3 signaling in processes that control neuron 
number in the developing telencephalon have been established. 
In contrast, functions of GSK-3 in regulating developing cortical neurons are much 
less clear.  Multiple in vitro studies have suggested roles for GSK-3 in regulating neuronal 
polarity and subsequent axonal and dendritic outgrowth and branching (See Hur and Zhou 
for review).  These functions are thought to be mediated via GSK-3 phosphorylation of 
microtubule associated proteins (MAPs) including collapsin response protein-2 (CRMP-2) 
(Yoshimura, Kawano et al. 2005), Adenomatous polypsis coli (APC) (Shi, Cheng et al. 2004; 
Zhou, Zhou et al. 2004), Tau (Stoothoff and Johnson 2005), microtubule associated protein 
1B (MAP1B) (Trivedi, Marsh et al. 2005), Doublecortin (DCX) (Bilimoria, de la Torre-
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Ubieta et al. 2010), and subsequent regulation of cytoskeletal dynamics.  In general, 
inhibition of GSK-3β via serine 9 (ser9) and GSK-3α via serine 21 (ser21) phosphorylation 
and subsequent relief of phosphorylation of downstream targets is thought be required for the 
formation of the axon and subsequent axon growth (Jiang, Guo et al. 2005; Hur and Zhou 
2010).  In a similar vein, a study employing in utero electroporation of an activating 
construct suggested that GSK-3 inhibition was essential for radial-guided cortical neuronal 
migration downstream of LKB1 via a mechanism involving APC (Asada and Sanada 2010).  
A prediction of this work might be that GSK-3 deletion would enhance axon growth and 
radial migration.  However, to date these effects of GSK-3 on neuronal polarity and 
migration have not been confirmed with mouse genetic studies.   Further, mice with point 
mutation knockins that prevent ser9/21 phosphorylation are viable and have not been 
reported to show defects in neuronal morphology or migration (McManus, Sakamoto et al. 
2005; Gartner, Huang et al. 2006).
We have now assessed GSK-3 functions in newly born cortical neurons using Nex 
(NeuroD6)-cre (Goebbels, Bormuth et al. 2006) to mediate recombination in INPs and newly 
born excitatory neurons in GSK-3 null and conditional alleles.  We demonstrate, surprisingly, 
that GSK-3 activity is essential for radial neuron migration in all areas of the cortex and in 
the hippocampus.  Remarkably, the migration effects appear to be independent of Wnt/β-
catenin signaling that mediates GSK-3 functions in neuronal progenitors.  At later stages 
GSK-3 signaling is also essential for dendritic polarization.  GSK-3 regulation of migration 
and morphology is correlated with reduced phosphorylation of DCX on ser327 and CRMP-2 
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on Thr514.  We conclude that GSK-3 is a critical regulator of migration and morphogenesis 
and that GSK-3 regulation is mediated by phosphorylation of key cytoskeletal proteins.
5.3 Results
GSK-3 signaling is essential for migration of cortical excitatory neurons
 To investigate the function of GSK-3 in developing cortical neurons, we generated 
GSK-3α-/-GSK-3βloxp/loxp: Nex-cre mice (GSK-3:Nex).  The Nex-cre line induces 
recombination in intermediate progenitors of the dorsal telencephalon and early postmitotic 
neurons beginning at approximately embryonic day 11 (E11) (Goebbels et al., 2006).  Prior 
studies using crosses with reporter lines indicate that recombination occurs in virtually all 
excitatory pyramidal neurons in the dorsal telencephalon (Goebbels et al., 2006; Monory et 
al., 2006).  Western blot analysis of lysates from the whole cortex, shows a 60% decrease in 
GSK-3β protein at E19.5 as compared with heterozygous litter mates [Supplemental Figure 
5.1A].  Remaining GSK-3β protein in the mutants is likely due to lack of recombination in 
interneurons and developing glia.  At E19, GSK-3:Nex brains are roughly the same size as 
littermate controls.  However, GSK-3:Nex mice die shortly after birth (P0-P3) for reasons 
that have not yet been determined.
 To explore neuronal functions of GSK-3, we first assessed cortical lamination at E16, 
a time of rapid neuronal migration along radial glial processes.  Deep layer neurons appeared 
to be normally positioned [Supplemental Figure 5.1B]. Thus staining with Tbr1, a layer 6 
marker, revealed a distinctive band in the deeper layers of the cortex in both controls and 
GSK-3:Nex  mutants.  In contrast, we noted clear abnormalities in the localization of Cux1 
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expressing neurons that normally populate Layers 2/3 [Supplemental Figure 5.1B].  A clear 
band of Cux1 positive neurons has formed in controls by E16.  In contrast GSK-3:Nex mice 
exhibit a dispersion of Cux1 cells with fewer neurons reaching the outermost layer, even at 
this early developmental stage.
 Dramatic mislocalization of layer 2/3 neurons was apparent by E19.5. Coronal 
sections through developing somatosensory cortex showed a large population of Cux1 
expressing neurons essentially “stuck” in the intermediate zone and throughout the deeper 
cortical layers (orange arrows) [Figure 5.1A-A’]. Indeed some Cux1 expressing neurons in 
mutants were observed in the ventricular zone (arrowhead). Higher power images showed 
that although a few Cux1 neurons migrated successfully to layer 2/3 (yellow denoted area), 
migration of most Cux1 expressing cells failed in the mutants  [Figure 5.1B-B’].  
 The migration defect (arrows) in GSK-3:Nex mutants was striking along the entire 
rostrol/caudal axis at E18.5 as observed in parasaggital sections [Figure 5.1C-C’].   The 
migration defect was particularly prominent anteriorly, a developmental profile 
corresponding to the neurogenic gradient of the developing cortex (Caviness et al., 2009).  
Images at P3 demonstrated persistent migration failure with almost uniform dispersion of 
Cux1 neurons across all cortical layers [Supplemental Figure 5.1C].  Whether the subset of 
normally placed neurons did not undergo recombination at an early enough stage for 
migration to be regulated could not be determined.
 We also generated GSK-3αloxp/loxp, GSK-3βloxp/loxp: Nex-cre mice 
(GSK-3loxp:Nex) using a GSK-3αloxp/loxp mouse line which harbors loxp sites flanking 
exon 2 of GSK-3α (Doble et al., 2007).. Interestingly, mice with floxed alpha rather than null 
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alpha alleles survived somewhat longer than the GSK-3:Nex mice but died after the second 
postnatal week (P15-P17).  Western blot analysis of lysates from the whole cortex at P0, 
shows a 85% decrease in GSK-3α and a 76% decrease in GSK-3β protein when compared 
with wild type littermate controls [Supplemental Figure 5.2B-C].  At P7 GSK-3loxp:Nex 
mutants exhibited a striking lamination phenotype involving Cux1 neurons [Supplemental 
Figure 5.2A].  This persistent lamination defect demonstrates that GSK-3 deletion results in 
permanent migration failure and does not simply result in a delay.  
Specificity of GSK-3 signaling for radial migration
 Importantly, the migration defect in the developing cortex is specific to excitatory 
pyramidal neurons.  In order to monitor the interneuron pool we used the DLX5/6-cre 
(Monory et al., 2006) line to generate conditional mice lacking GSK-3 differentiating 
GABAergic interneurons.  Interneuron migration was monitored using the AI3 reporter line 
(Monory et al., 2006) (GSK-3-AI3:DLX).  Surprisingly, in both controls and GSK-3 mutants, 
interneurons exhibited robust migration along the two migratory streams (yellow arrows) 
from the medial ganglionic eminence (MGE).  In GSK-3 mutants, as in controls, interneurons 
entered all areas of the cortical plate by E19.5 [Figure 5.2A-A’].  
 In order to assess the generality of GSK-3 regulation of radial migration, we assessed 
migration in developing hippocampus.  The hippocampus, like the cortex, is an area where 
developing neurons migrate along radial glial like processes (Eckenhoff and Rakic, 1984; 
Nowakowski and Rakic, 1979).  Nex-cre expression is evident in developing hippocampal 
neurons as early as E14 (Goebbels et al., 2006), allowing us to delete GSK-3 in those cells.  
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Pyramidal neurons generated from the hippocampal primordia undergo migration along 
radial processes to form CA1/CA3 and the dentate gyrus (DG) (Altman and Bayer, 1990) 
[Figure 5.2B].  The transcription factor CTIP2 marks neurons in the developing CA1 region. 
GSK-3:Nex mice exhibited a striking hippocampal migration defect.  CTIP2 expressing 
neurons did not migrate properly (yellow arrows) and as a consequence CA1 did not fully 
develop [Figure 5.2B-B’].  As a result, CA1-3 and the DG (arrowheads) were disorganized 
and the hippocampal sulcus was not well defined [Figure 5.2C-C’’].  These defects were 
striking in rostrol areas as shown although somewhat less pronounced in caudal sections 
(data not shown).  Interestingly, fimbrial axonal projections (orange arrow) formed in 
GSK-3:Nex mice demonstrating that even though migration fails, hippocampal neurons were 
able to polarize and extend appropriately directed axons [Figure 5.2B]. 
GSK-3 regulation of migration is cell autonomous 
 To assess whether the migration defect was cell autonomous and to visualize 
morphology of GSK-3 deleted neurons, we introduced Cre and EGFP into a subpopulation of 
developing neurons in GSK-3α-/-GSK-3βloxp/loxp mice.  NeuroD6 Cre (NeuroD-Cre) and 
LacZ/EGFP (Z/EG) were injected into the ventricles and co-electroporated at E14-15.5.  
Electroporation at this age targets radial progenitors that generate mainly upper layer 
neurons.  This co-electroporation technique allowed us to visualize individual GSK-3 deleted 
neurons in an otherwise control background.  Labeled neurons were imaged at late 
embryonic and postnatal stages. 
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 Deletion of GSK-3 in individual neurons phenocopies the migration delay seen in the 
GSK-3:Nex mutants.  At E19 most control neurons were located in the upper cortical layers 
as expected [Figure 5.3A].  In contrast, most GSK-3 deleted neurons had cell somas that 
were localized to the deeper layers of the cortex, very few were found in upper layers 
[Figure 5.3A’].  Importantly, GSK-3 deleted neurons were clearly able to project axons 
(orange arrows) suggesting that initial polarization had proceeded in the absence of GSK-3.  
Further, most GSK-3 null neurons in the cortical plate elaborated a long leading process 
directed toward the pial surface (arrowheads) [Figure 5.3A’]. Thus at least the initial stages 
of dendritic arborization also appeared to proceed in the absence of GSK-3.
 The GSK-3 migration defect was strikingly persistent into the postnatal period.  In 
mice electroporated at E14-15.5 and analyzed at P10, GSK-3 deleted neurons remained in the 
deeper layers and subcortical white matter [Figure 5.3B-B’].  EGFP expressing neurons co-
labeled with Cux1 (red) demonstrating that they were able to acquire the proper laminar 
markers but were unable to attain the proper position [Figure 5.3D, arrows].  Again, long 
apical processes that reached the pial surface were elaborated by GSK-3 deleted neurons.  
Arborization was apparent in layer 1 [Figure 5.3D, yellow arrowheads], basal dendrites 
formed, and axons projecting towards the corpus callosum were evident.  Thus GSK-3 
regulates some critical aspect of migration but not the early stages of axon and dendrite 
formation (see below). 
 In quantifying our results, we found that in control animals the majority of 
electroporated neurons (73.7%) were found in the upper layers of the cortex (yellow bars) by 
P10 [Supplemental Figure 5.3AB].   In contrast, GSK-3 deleted neurons remained in the 
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deeper layers of the cortex and only 23% had reached the upper layer 2/3 by P10 
(p=<0.005) .  
GSK-3 deletion in post-mitotic neurons delays multipolar to bipolar transition 
 A number of in vitro studies have suggested that GSK-3 regulates neuronal 
polarization.  It is plausible that some defect or delay in the polarization might account for 
migration failure.  To test this idea, we electroporated NeuroD-Cre and Z/EG into the 
GSK-3α-/-GSK-3βloxp/loxp cortex, plated cortical cells in dissociated culture and assessed 
stage progression at three days in vitro (3DIV).  We observed no statistically significant 
difference in the stage progression between control and GSK-3 deleted neurons 
[Supplemental Figure 5.4A].  Further, GSK-3 deleted neurons that successfully extended an 
axon remained highly dynamic [Supplemental Figure 5.4B] and extended and retracted 
neurites. Thus at least some processes that require complex cytoskeletal regulation proceed 
normally in the GSK-3 deleted neurons.  
 To assess the cell biological mechanisms of GSK-3 regulation of neuronal migration, 
we co-electroporated NeuroD-Cre;Z/EG or a control pCAG-dsRED construct into the lateral 
ventricles of control and GSK-3α-/-GSK-3βloxp/loxp mice.  This was followed by live 
imaging of migration ex vivo in a cortical slice preparation (Hand and Polleux, 2011) at 
3DIV.  In controls, electroporated with pCAG-dsRED, labeled neurons transitioned from 
multipolar to bipolar morphology and migrated through the cortical plate over a period of 12 
hours, as expected [Figure 5.3E].  The progress of individual neurons could readily be 
tracked and is indicated for 3 examples by the progress of the colored arrowheads in the 3 
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panels.  In contrast GSK-3-deleted neurons failed to translocate through the intermediate 
zone and remained in a multipolar state in the outer subventricular zone (arrowheads) 
[Figure 5.3E, and supplemental movie 5.1].   Further, during the 12 hours of observation 
most GSK-3 deleted neurons did not transition to a bipolar morphology, a step thought to be 
required for radial-guided migration.  
GSK-3 regulation of axonal and dendritic morphology 
  GSK-3’s ability to regulate multiple cytoskeletal proteins would suggest that 
GSK-3 deletion would have profound effects on dendrite and axonal arborization.  Indeed, 
GSK-3 inhibition in vitro regulates development of neuronal polarity as well as axon growth 
and branching (reviewed in Hur and Zhou, 2010).  To address GSK-3 regulation of 
morphology we deleted GSK-3 cell autonomously by in utero electroporation and analyzed 
dendritic morphology and axon targeting at P15.
 As demonstrated above, most GSK-3 deleted neurons failed to migrate and populated 
the deeper layers of the cortex at P15 [Figure 5.4A,A’;B,B’].  Despite mispositioning, 
GSK-3 deleted neurons extended axons into the callosum towards the contralateral cortex 
[Figure 5.4C].  In controls we observed axons branching extensively in layers 2/3 and 5 of 
the contralateral cortex, as previously described (Hand and Polleux, 2011) [Figure 5.4D].  In 
contrast, GSK-3 deleted axons reaching the contralateral cortex very rarely entered the 
cortical plate and the axons did not arborize in layers 2/3 or 5 [Figure 5.4C’].  Whether this 
failure of arborization is a result of deficient axon growth or lack of responsiveness to 
specific targeting cues remains unclear. 
64
 We also analyzed the dendritic arborization in GSK-3 deleted neurons.  Many GSK-3 
deleted neurons exhibited striking defects in the apical dendrite and misorientation of the 
basal dendrites [Figure 5.5].  Because improper laminar position might affect dendritic 
arborization we focused analysis on a small subset of GSK-3 deleted neurons that reached 
layer 2/3.  Remarkably, these normally positioned GSK-3 deleted neurons also exhibited 
abnormally oriented basal dendrites that in many cases, were oriented towards the pial 
surface rather than towards the deeper cortical layers [Figure 5.5C].  The apical dendrites of 
the GSK-3 deleted neurons properly oriented to the pial surface but often branched and 
extended apically rather than laterally [Figure 5.5D].  Examples of markedly abnormal 
apical dendrites (orange arrows) and abnormally oriented basal dendrites (blue arrowheads) 
are shown in Figure 5.5B.
GSK-3 regulation of migration is independent of Wnt/β-catenin signaling
 Signaling via β-catenin is an obvious candidate to mediate GSK-3 regulation of 
migration.  In the canonical Wnt cascade, Wnt signaling through the frizzled receptor leads to 
dishevelled and GSK-3 sequestration, β-catenin accumulation and enhanced transcription 
(Kaidanovich-Beilin and Woodgett, 2011).  In radial progenitors, β-catenin signaling is 
clearly an important mediator of the effects of GSK-3 deletion (Chenn and Walsh, 2002; Kim 
et al., 2009).  
 To determine the role of GSK-3 regulation of β-catenin in the cortical migratory 
pathway, we utilized a β-catenin mouse that harbors loxP sites flanking exon 3 
(βcatEx3:Nex) (Harada et al., 1999).  Exon 3 encodes the residues that GSK-3 
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phosphorylates to signal β-catenin degradation; thus deleting exon 3 renders β-catenin 
unresponsive to GSK-3 regulation.  In contrast to GSK-3:Nex, βcatEx3:Nex mice survive, 
breed and have no overt behavioral phenotype.  They display a rostral midline defect 
resulting in a lack of the hippocampal commissure [Figure 5.6A, arrow], as seen in other 
models using stabilized β-catenin (Chenn and Walsh, 2003).  However, βcatEx3:Nex mutants 
exhibit normal cortical lamination and normal distribution of Cux1 neurons in the upper 
cortical layers [Figure 5.6B].  These data suggest that the migration defect associated with 
GSK-3 deletion may be independent of Wnt/β-catenin signaling.  
 Further supporting the concept that β-catenin may not be a critical mediator of 
migration, is that GSK-3loxp:Nex lysates at P0, an age when the migration phenotype is well 
developed, show little if any change in β-catenin protein levels [Supplemental Figure 5.2B]. 
We cannot rule out changes that would be masked by the dilution effect of non-recombined 
cells, changes confined to specific cellular compartments, or changes that might be more 
apparent later in development.  For additional assessment of the role of β-catenin signaling 
we performed global analysis of GSK-3 transcriptional targets at E18 in control and 
GSK-3:Nex cortical lysates using affymetrix microarray analysis.  Consistent with loss of 
GSK-3 in our conditional mutants, probe level information specific to exon 2 of GSK-3β 
showed that exon 2 was decreased by an average 2.15 fold [Figure 6C].  However, classic 
WNT pathway target genes downstream of β-catenin/(TCF)/LEF-1 transcription factors, 
including CyclinD1, Brachyury, Wisp1, Cdx1, Engrailed2, and Neurogenin 1 were 
unchanged. 
66
 To further assess the role of Wnt/β-catenin signaling in cortical lamination we created 
a conditional dishevelled 2loxp/loxp (Dvl2) mouse.  We then generated a triple mutant by 
crossing our floxed Dvl2loxp/loxp with existing Dvl1 and Dvl3 nulls and the Nex-Cre line 
(DVL123:Nex).  Deletion of all three DVLs presumably completely abrogates Wnt signaling 
via the canonical pathway.  Remarkably, lamination in the triple allele mutant Dvl123:Nex 
appears relatively normal at E18 [Figure 5.6D].   This result further supports the idea that 
GSK-3 regulation of migration is not mediated by the WNT/β-catenin cascade.   
 Taken together, these three lines of evidence suggest that migration defects in GSK-3 
deleted neurons are not mediated by changes in β-catenin signaling.
Surprising lack regulation by LKB1, CDC42, PTEN
 Recent work utilized RNAi and GSK-3 S9A mutant constructs to conclude that LKB1 
inactivation of GSK-3 via ser9 phosphorylation alters neuronal migration (Asada and Sanada, 
2010).  However, GSK-3 knock-in S9A/S21A GSK-3 ‘constitutively active’ mice develop 
normally and migration defects have not been reported (Gartner et al., 2006; Jiang et al., 
2005).  These results indicate that ser9/ser21 phosphorylation status may not correlate with 
the neurodevelopmental function of GSK-3 in vivo.  To further address the issue of GSK-3 
inhibition downstream of LKB1, we genetically deleted LKB1 from developing excitatory 
neurons (LKB1:Nex).  LKB1:Nex mutant mice die around P20.  Perhaps surprisingly, no 
lamination abnormalities were observed [Fig 5.6E].  These results suggest that LKB1 
regulation of GSK-3 activity is not essential for radial-guided neuronal migration in vivo.
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 In Receptor Tyrosine Kinase (RTK) cascades, GSK-3 lies downstream of PI3K/PIP/
AKT.  Signals transduced through these cascades inhibit GSK3 by phosphorylation on Ser9/
Ser21 (Hur and Zhou, 2010).  The phosphatase PTEN suppresses PI3K signaling.  To 
determine if PI3K signaling affects migration we genetically deleted PTEN in neurons using 
Nex-Cre.  Though PTEN:Nex mutants die around birth, no overt lamination defects were 
observed [Figure 5.6E].  
 Finally, we deleted a key regulator of Par6-aPKC, CDC42, using Nex-Cre.  aPKCs 
are also known to phosphorylate Ser9/Ser21 of GSK-3 (Etienne-Manneville and Hall, 2003). 
CDC42:Nex mutants also die shortly after birth, but again we observed no lamination defect 
in these mutant mice [Figure 5.6E].  
 These findings taken together suggest that regulation of GSK-3 phosphorylation at 
ser9/ser21 is not important in the control of radial migration.
Phosphorylation status of GSK-3 substrates
 To determine the status of relevant GSK-3 targets we conducted western blot analysis 
of GSK-3 substrates that have been implicated in migration regulation.  As noted above, β-
catenin levels were not dramatically changed raising the possibility that β-catenin is regulated 
differently in post-mitotic neurons versus progenitors. Also we did not detect changes in 
pSer722 FAK (Bianchi et al., 2005), pSer dynamin-1(Clayton et al., 2010) and pSer129 
CREB(Bullock and Habener, 1998; Fiol et al., 1994) [Figure 5.7B].  Presumably other 
kinases contribute to phosphorylation of the putative GSK-3 sites in vivo.  
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 Interestingly, deletion of GSK-3 drastically reduced the phosphorylation of two key 
proteins previously implicated in migration. GSK-3loxp:Nex mutants showed an 80% 
decrease in phosphorylated CRMP2 on Thr514  and a 61% decrease in phosphorylated  DCX 
on Ser327 (Gdalyahu et al., 2004)  [Figure 5.7A].  Changes in the phosphorylation status of 
these proteins has been implicated in migration, raising the possibility that reduced functions 
of these proteins toward microtubules mediate GSK-3 effects.
5.4 Discussion
Overview
 In this work, we have documented a requirement for cell autonomous GSK-3 
signaling in multiple aspects of the development of cortical excitatory neurons.  GSK-3 
activity is critical for the radial migration of later born, Cux1-expressing neurons in all 
regions of cortex.  Few Cux1 neurons can migrate to upper layers in GSK-3 deleted mice and 
regulation of migration is clearly cell autonomous.  Whether the few neurons that 
successfully migrate do so in a GSK-3 independent manner or whether the timing of GSK-3 
deletion leaves some neurons with residual GSK-3 activity could not be determined. 
 The GSK-3 requirement appears to be specific for radial migration.  Migration of 
both GSK-3 deleted cortical and hippocampal neurons along radial processes was 
dramatically impaired.  In contrast, tangential migration of neurons deriving from MGE 
progenitors was not clearly affected. The migration failure was persistent and readily 
apparent at P15, the latest time point examined. 
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 At later developmental stages, additional abnormalities were noted. Perhaps 
surprisingly, GSK-3 deleted neurons elaborated appropriately directed axons that elongated 
for substantial distances.  However, after crossing the corpus callosum, axon  branching and 
invasion of target fields in contralateral cortex was compromised.  Further, abnormalities of 
dendritic arborization were readily apparent.  Normally, cortical projection neurons in layer 
2-3 have an apical process reaching the pial surface, but basal dendrites that are directed 
laterally and towards the ventricular zone. In striking contrast, basal dendrites of GSK-3 
deleted neurons almost invariably pointed upwards towards the pial surface. 
GSK-3 regulation of cortical development
 Our work builds on a growing body of evidence establishing critical requirements for 
GSK-3 in cortical development, with different functions characterizing different stages of 
development.  In radial progenitors, GSK-3 signaling is a critical regulator of proliferation.  
GSK-3 deletion leaves cells “locked” into the proliferative phase due to regulation of 
proliferation drivers via β-catenin and other signaling mediators.  At a later stage, recent 
work has demonstrated that GSK-3 is a key mediator of the amplification of the INP pool via 
interactions with the scaffolding protein Axin (Fang et al., 2013).  Axin-GSK-3 binding in the 
cytoplasm is clearly required for expansion of the INP pool, although the mechanism of 
GSK-3 action was not specified in this study.  Interestingly β-catenin regulation of 
transcription in the nucleus was required for differentiation of INPs into neurons.  These 
effects of GSK-3 signaling on radial progenitors and INPs would clearly strongly influence 
cortical neuronal number in the developing cortex.
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 We now find that at later stage, excitatory neuron development is also under 
important GSK-3 regulation.  Thus, Cux1 expressing neurons require GSK-3 activity for 
migration along radial processes.  GSK-3 deletion leads to migration failure of Cux1 positive 
cells in all regions of the dorsal telencephalon.  The behavioral consequences in GSK-3 
deleted mice could not be assessed due to early death of the animals.  Whether death was due 
to cortical abnormalities or defects in other cells that underwent recombination with Nex-Cre 
could not be determined. However, even a very mild form of this type of migration defect 
would be catastrophic for human brain development. 
 In contrast to regulation of progenitor proliferation and neural differentiation, GSK-3 
regulation of migration appears to be independent of Wnt/β-catenin signaling.  Interestingly, 
the migration defect also appears to be independent from one recently associated with 
mutants of the schizophrenia associated protein, DISC1.  DISC1 regulates progenitor 
proliferation via interactions with GSK-3, decreased GSK-3 kinase activity and, ultimately, 
increased β-catenin signaling see (Mao et al., 2009).  Interestingly, a recent study 
demonstrated that DISC1 regulates migration independently of GSK-3 via effects on the 
centrosome (Ishizuka et al., 2011).  However, our work reported here clearly demonstrates 
that GSK-3 also has a critical role in the regulation of cortical neuronal migration. 
Radial migration is an enormously complex process requiring progenitor differentiation, 
dramatic morphological change, intricate mechanisms for cell and nuclear movements and 
sensing of multiple cues that start and stop the process.  Not surprisingly, GSK-3 joins 
dozens of other molecules implicated in the control of radial migration (see (Ayala et al., 
2007) for review).  Comparisons with the literature suggest that effects of GSK-3 deletion are 
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among the most severe that have yet been observed.  Interestingly, GSK-3 importantly 
regulates multiple proteins implicated in migration and is an important mediator in several of 
the signaling pathways involved. Thus GSK-3 is known to phosphorylate Doublecortin 
(Bilimoria et al., 2010), FAK (Bianchi et al., 2005), dynamin (Clayton et al., 2010), 
neurogenin (Li et al., 2012), CRMP-2 (Uchida et al., 2005), and MAP1B (Trivedi et al., 
2005). Further GSK-3 mediates Reelin signaling (Beffert et al., 2002), LKB1 effects (Asada 
and Sanada, 2010), cdc42 effects (Etienne-Manneville and Hall, 2003), integrin signaling 
(Guo et al., 2007), semaphorin signaling (Eickholt et al., 2002; Uchida et al., 2005) and other 
pathways that have been implicated in control of radial migration.  Finally, GSK-3 shares 
multiple substrates with CDK5, a kinase that is situated among the most important neuronal 
intrinsic regulators of migration.
 Clearly GSK-3 effects on cortical development extend well beyond the phase of 
neuronal migration.  At stages when axons are projecting to target fields and dendritic arbors 
are maturing, there continues to be striking regulation by GSK-3.  Interestingly the reported 
effects of deleting GSK-3 in vitro are quite different than the in vivo effects we demonstrate 
here (see below).  From prior studies one might have expected that neurons would elaborate 
multiple axons, branch extensively, and that dendritic arborization would be suppressed (see 
Hur and Zhou, 2010 for review).  We demonstrate here that GSK-3 deleted neurons can 
clearly elaborate axons and dendrites both in vitro and in vivo.  Differences with prior in 
vitro studies using inhibitors, silencing RNAs, and activated constructs may relate to the 
exact timing of full GSK-3 deletion, off-target effects of other techniques, or differences 
between contextual and dissociated preparations.
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 Although dendritic arbors form, dendritic arborization abnormalities are striking in 
GSK-3 deleted neurons.  Importantly, abnormalities in apical and basal dendrite orientation 
have been noted after deletions of guidance molecules and guidance molecule signaling 
pathways.  In particular, interference with semaphorin signaling produces a similar type of 
interference with apical process development and orientation of basal dendrites (see below).
Mechanisms of GSK-3 regulation
 In general GSK-3 acts via two classes of mechanisms: one where GSK-3 activity 
inhibits substrate function or availability and another where GSK-3 activity is required for 
substrate function.  Therefore, we might expect GSK-3 deletion to enhance processes 
normally inhibited by GSK-3 activity and to inhibit processes that require GSK-3 activity.
 Multiple studies have suggested that inhibition of GSK-3 kinase activity is important 
to morphological functions such as establishment of neuronal polarity and cellular migration. 
For example, several in vitro studies have shown that appropriate regulation of GSK-3β ser9 
phosphorylation downstream of Akt is key to establishment of hippocampal neuron polarity.  
Increasing inhibition results in formation of multiple axons at the expense of dendritogenesis 
(Jiang et al., 2005; Yoshimura et al., 2005).  Effects of GSK-3 inhibition are thought to be 
mediated by dephosphorylation of CRMP-2, APC and other cytoskeletal mediators with 
resulting stabilization of microtubules at the tips of axons (Hur and Zhou, 2010; Yoshimura et  
al., 2005).  In a similar vein, astrocyte migration is thought to be mediated in vitro by a 
CDC42/aPKC mediated ser9 phosphorylation of GSK-3β, dephosphorylation of APC with 
localization to the microtubule tips, and subsequent stabilization of microtubules at the 
leading edge (Etienne-Manneville and Hall, 2003).  Another recent study employing in utero 
73
electroporation of constructs suggested that an LKB1/GSK-3 pathway resulting in GSK-3β 
ser9 phosphorylation and APC localization at the leading edge was important in cortical 
neuronal migration (Asada and Sanada, 2010).
 In the studies outlined above, inhibition of GSK-3β kinase activity is indicated by 
phosphorylation on Ser9, and inhibition of GSK-3α by phosphorylation on Ser21.  However, 
a major unresolved paradox is that mice with GSK-3 α and β point mutation knock-ins that 
prevent ser9 and ser21 phosphorylation respectively show no widespread morphological 
abnormalities in vitro or in vivo (Gartner et al., 2006).  Similarly, truncation mutants of the 
Drosophila GSK3- homologue, Shaggy, that lack inhibitory phosphorylation sites are not 
associated with morphological abnormalities (Papadopoulou et al., 2004).  In the context of 
neuronal migration, although GSK-3 ser9/21 phosphorylation is enhanced downstream of 
Reelin signaling (Beffert et al., 2002; Gonzalez-Billault et al., 2005), surprisingly GSK-3β 
kinase activity towards the important substrate MAP1B is increased (Gonzalez-Billault et al., 
2005).  Finally, our findings reported here do not support critical roles in radial migration for 
LKB1, cdc42, or the PI3K pathway, all of which are known to regulate GSK-3 ser9/21 
phosphorylation.  These findings, taken together, raise questions about the importance of 
negative regulation of GSK-3β via Ser9 phosphorylation on functions of microtubule binding 
proteins related to migration in vivo.
 Our results are more in line with a second type of regulation, GSK-3 activity being 
required for normal substrate function. Several proteins have been shown to require GSK-3 
kinase activity for normal function. These include DCX where GSK-3 mediated 
phosphorylation is thought to be required for DCX’s actions in regulating axon branching 
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and possibly in migration (Bilimoria et al., 2010).    Additional examples possibly relevant to 
migration are GSK-3 regulation of neurogenin phosphorylation at ser231 (Ma et al., 2008), 
FAK phosphorylation at ser722 (Bianchi et al., 2005) and dynamin-1 phosphorylation of 
ser774 (Clayton et al., 2010).  GSK-3 phosphorylation regulates functions of these proteins in 
complex ways, but possibly in ways that may be required for neuronal migration. 
 A well studied example of a pathway that is associated with upregulation of GSK-3 
activity is semaphorin signaling.  Semaphorin family members have multiple roles as 
chemorepellants and chemoattractants for many classes of axons and dendrites (for review 
see (Pasterkamp, 2012)).  Semaphorin signaling activates GSK-3 (Eickholt et al., 2002) 
resulting in phosphorylation of a key MAP, CRMP-2 (Uchida et al., 2005). In vitro, CRMP-2 
phosphorylation is associated with axonal growth cone collapse, whereas CRMP-2 
dephoshorylation is associated with formation of multiple axons in hippocampal cultures 
(Brown et al., 2004).  Intriguingly, during neuronal polarization semaphorin signaling is 
associated with suppression of axons and formation of dendrites (Shelly et al., 2011).
Importantly, migration and dendritic abnormalities that we have described here are consistent 
with cortical neuron phenotypes reported due to manipulation of semaphorin signaling.  Thus 
application of exogenous semaphorin supports apical process formation and dendritic 
arborization (Polleux et al., 2000).  Further interfering with semaphorin, NP1 or Plexin via 
silencing RNAs and gene knockouts has been reported to interfere with radial migration 
(Chen et al., 2008; Renaud et al., 2008).  Many of the same manipulations have resulted in 
branched apical dendrites and abnormal dendrite orientation (Morita et al., 2006; Nakamura 
et al., 2009).  Although GSK-3 deletion does not exactly phenocopy these previously 
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reported semaphorin effects, there are enough similarities to suggest that GSK-3 deletion 
effects may be due at least in part to abrogation of semaphorin signaling.  Finally, in the 
context of cortical neuronal migration, phosphorylation of CRMP-2 promotes migration.  
Thus a GSK-3 phosphomimetic CRMP-2 can rescue migration defects associated with 
knockdown of the semaphorin signaling mediator, α2-chimaerin (Ip et al., 2012).  
 Conclusion:
In sum we have demonstrated a key cell autonomous role for GSK-3 signaling in regulating 
radial migration and morphological development of cortical excitatory neurons.  Our GSK-3 
deletion results are not in line with what might have been predicted form prior studies that 
have correlated ser9/21 phosphorylation with relief of negative GSK-3 phosphorylation and 
negative regulation of cytoskeletal associated proteins.  In particular we do not find evidence 
that an LKB1/GSK-3 inhibitory pathway is a key migration regulator.  In contrast, our results 
are consistent with the idea GSK-3 phosphorylation of DCX and CRMP2 are required for 
appropriate cytoskeletal regulation and migration.  Finally, our data are consistent with the 
idea that GSK-3 activity is essential for many of the effects of semaphorin signaling on 
cortical development. 
5.5 Experimental Procedures
 Generation of Conditional Mice
 Mice were cared for according to animal protocols approved by the Institutional Animal 
Care and Use Committees of the University of North Carolina at Chapel Hill.
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GSK-3α-/- mice possessing exon 2 deletions and GSK-3α/β loxp flanked exon 2 mice have 
been previously described (MacAulay, Doble et al. 2007; Patel, Doble et al. 2008).  All 
GSK-3 lines were generously provided by Jim Woodgett.  GSK-3:Nex mice were generated 
by mating GSK-3α-/-, GSK-3loxp/loxp with Nex:Cre mice generously provided by Dr. KA Nave 
(Goebbels, Bormuth et al. 2006).  GSK-3 mutant mice and Nex-Cre mice were maintained on 
a mixed background.  Triple allelic male mutants (GSK-3α+/-βf/f:Nex) fail to survive unto 
adulthood with death occurring around P25 for reasons not yet determined and GSK-3α-/- 
males are infertile, as previously reported (Maurin, Lechat et al. 2013).
 Ctnnb1 exon 3 floxed (β-catenin constitutively active) mice were previously described 
(Harada, Tamai et al. 1999).  LKB1 floxed mice have been previously described (Bardeesy, 
Sinha et al. 2002).  PTEN floxed mice (Groszer, Erickson et al. 2001) and CDC42 floxed 
mice were purchased from Jackson Laboratory and have previously been described (Chen, 
Liao et al. 2006).
 Dvl2 floxed allele was generated in the UNC Neuroscience Center Molecular 
Neuroscience Core using conventional methodology.  Dvl1and Dvl3 (Tsang, Lijam et al. 
1996) knockout mice were purchased from from Jackson Laboratory and have been 
previously described.  All mice are on a mixed background.
 Results shown in all of the figure panels were based on at least three experiments with 
mice from independent litters, unless otherwise noted.
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In Utero Electroporation
 Mice were anesthetized using either 2,2,2-Tribromoethanol (4mg/10 g mouse) or 
isofluorine and embryos were exposed at E14.5 or E15.5. Plasmids (2ug/ul NeuroD-Cre and 
1ug/ul Z/EG) mixed with fast green were then microinjected into the lateral ventricle of 
embryos. Embryos were electroporated with five 50 ms pulses at 30V with a 950 ms interval 
and returned to the abdominal cavity [Supplemental Figure 5.5].  A CF1 foster dam was 
used to aid postnatal survival studies.  Depending on the experiment mice were analyzed at 
E19.5, P6, P10 or P15.  
Ex vivo Electroporation and organotypic cortical slice culture
 Cortical progenitor cells were electroporated ex vivo at E15.5 as described previously 
(Hand et al., 2005). Briefly, E15.5 embryos were decapitated, plasmids were injected into 
lateral ventricle followed by electroporation with four 30V pulses that were 40ms in duration 
and separated by a 100ms interval. Following electroporation, brains were dissected and 
vibratome sectioned at 250µm. Slices were transferred to Poly-D-Lysine and laminin coated 
culture insert (Millicell, Millipore) in a FluoroDish (World Precision Instruments), then 2ml 
Basal Medium Eagle with FBS, N2 (Gemini, 400-163), B27 (Gibco, 17054-044),  penicillin-
streptomycin (Gibco, 15140-122) and L-glutamine (Gibco, 25030-081) supplements were 
added.  Slices were cultured for 3 days at 37ºC and live imaged using an Olympus FV1000 
Confocal microscope with stage incubator.
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Cortical Progenitor Dissociated Cultures
 E14.5-15.5 dorsal cortices were electroporated with NeuroD-Cre; Z/EG,  dissected in 
4ºC Hank’s Balanced Salt Solution (HBSS; Gibco) and dissociated into single cells using 
Trypsin (Gibco) according to previously described methods (Hand, Bortone et al. 2005). 
Neurons were plated on glass bottom dishes (MatTek) coated with 0.1mg/mL Poly-D-Lysine 
(Sigma) and 5µg/mL Laminin (Sigma). Cells were cultured in Neuralbasal-A Medium 
(Invitrogen), supplemented with 1X B-27 (Gibco), L-glutamine (Gibco), penicillin-
streptomycin (Gibco), N2 (Gemini) and FBS.  Neurons were fixed with 4% PFA and stained 
for stage progression analysis.  For stage progression analysis heterozygote controls were 
compared to conditionally deleted neurons (n=3, 1341 cells).
Western Blotting
 Mouse cortices were dissected from three control (GSK-3α-/-β loxp/+:Nex) and mutant 
(GSK-3:Nex) or three control (GSK-3αloxp/loxpβloxp/loxp) and three mutant (GSK-3αloxp/loxpβ loxp/
+:Nex) mice from independent litters, collected in RIPA lysis buffer supplemented with 
protease and phosphatase inhibitors and cleared by centrifugation.  Proteins were separated 
on SDS-PAGE gradient gels, transferred to a PVDF membrane and probed for GSK-3 
(Invitrogen), the internal control GAPDH (Cell Signaling), and secondary HRP-conjugated 
antibodies for detection.  Blots were washed and detection was performed with a 
commercially available ECL kit.  Image J software (NIH)  was used for quantification of 
band intensity relative to control.  Statistical analyses were conductive using Prism software.  
Differences were considered statistically significant at p< 0.05.  The following antibodies 
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were used: GSK-3 (Invitrogen), Actin (Cell Signaling), pFAK ser722 (santa cruz), FAK (Cell 
Signaling), pCRMP2 Th514 (cell signaling), CRMP2 (cell signaling), pCREB ser129 (santa 
cruz), CREB (santa cruz), pDCX ser327 (The Reiner lab), pDynamin-1 ser744 (santa cruz), 
Dynamin-1 (santa cruz), B-catenin (Cell Signaling), GAPDH (Cell Signaling), Cleaved 
Caspase-3 (Cell Signaling). 
Immunohistochemistry
 Briefly, 100-350µm free floating vibratome sections of brains were collected in PBS, 
blocked with 5% normal serum in PBS with 0.1% Triton X-100, and incubated with primary 
antibodies in blocking solution overnight at 4ºC.  For cryosectioned tissue samples were 
immunostained according to standard procedures.  P15 in utero vibratome sections were 
blocked with 5% normal serum in PBS with 0/1% Triton X-100 and 2% DMSO, and 
incubated with primary antibodies for 3 days.  Slices were rinsed with PBST for 24 hours and 
incubated with secondary antibodies for 3 days in PBS with 0/1% Triton X-100.  GSK-3 
staining conducted using Teramide Signal Amplification (PerkinElmer, NEL744001KT).   
  The following primary antibodies were used in our study:  L1 (Chemicon), Cux1 
(Santa Cruz), Neuronal Nuclei (Chemicon), GFP (Aves), CTIP2 (Abcam) DRAQ5 (Fisher), 
TBR1 (1:1000, Abcam), HOECHST (sigma, RFP (Rockland).  After rinsing, sections were 
then incubated with Alexa conjugated secondary antibodies (Invitrogen) overnight at 4ºC, 
rinsed 3 times in PBS, and mounted with gel/mount (Biomeda).
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Quantification of cortical layering
 GSK-3α+/-β F/F control mice and GSK-3α-/-β F/F conditionally deleted embryos and 
postnatal pups were cryosectioned at 200um and used for analysis.  The cortical plate was 
equally divided into five cortical bins [Supplemental Figure 3], cells in each bin were 
counted using ImageJ software and the percentage of GFP+  neurons in each bin were 
determined from multiple comparable sections.  Using this method, bins four and five 
correspond to the upper layer 2/3 Cux1 positive layers.  A total of 4209 neurons were counted 
and differences were considered statistically significant at p=< 0.05 using an unpaired t-test.
Image Acquisition and Analysis
 Images were collected on a Zeiss LSM 710 and/or Zeiss 510 NLO confocal 
microscope. Z-stack images were collected with 10X or 20X objectives and tiled together to 
generate high-resolution images of whole brain sections.  Axon fluorescence quantification 
was conducted with ImageJ.  Two photon images for P15 neuron tracings were collected 
using a Zeiss 7MP Multiphoton confocal microscope and cell tracings were conducted using 
Neurolucida. 
Affymetrix Microarray
 Dorsal cortices were dissected from three E18 Control (GSK-3α-/-β F/F) and mutant 
(GSK-3α-/-β F/F;NEX) embryos derived from two independent litters.  RNA was prepared 
using the MiRNAeasy kit (Qiagen) and analyzed using the Affymetrix Mouse Gene 2.0 St 
array.  Following scanning of the array, basic data analysis was carried out using the Partek 
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Genomics Suite Version 6.12.0712. Transcripts up or down-regulated by 1.5 fold were 
considered interesting candidates.
Reagents and Collaborations
 Dr. Franck Polleux (Columbia University) provided the NeuroD-Cre and Lox-STOP-
lox LacZ/EGFP (Z/EG) plasmids and LKB1 mutant mice.  CRMP2 plasmids were provided 
by Nancy Y. IP (The Hong Kong University of Science and Technology, China) and cloned 
into the NeuroD plasmid.  Doublecortin constructs provided by Azad Bonni (Harvard 
Medical School) and described previously (Bilimoria, de la Torre-Ubieta et al. 2010).  The 
phospho-DCX ser327/Thr321 antibody was provided Dr. Orley Reiner (Weizmann Institute 
of Science, Israel) and has been previously described (Gdalyahu, Ghosh et al. 2004).  Two-
Photon images were collected by Vladimir Ghukasyan of the UNC Neuroscience Center 
Confocal and Multipohoton Imaging Core.
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5.6 FIGURES AND FIGURE LEGENDS
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Figure 5.1.  GSK-3 signaling is essential for proper lamination of the developing cortex.
(A-A’) Cux-1 staining (red) in coronal sections from control and GSK-3:Nex mice at E19.5.  
Cux-1 neurons are strikingly mislocalized in GSK-3:Nex mutants (arrows) including a small 
population of neurons that remain in the ventricular zone (arrowhead).  Nuclei were 
counterstained with DRAQ5.  Scale bar = 500um.  (n=4)
(B-B’) Higher magnification of white boxes in (A).  The number of Cux-1 expressing 
neurons reaching layer 2/3 (denoted by yellow dashed lines) is markedly reduced in the 
GSK-3:Nex mutants.
(C-C’) Cux-1 staining in parasagital vibratome sections from control and GSK-3:Nex 
mutants at E18.5.  Cux-1 expressing neurons (arrows) are mislocalized in GSK-3:Nex 
mutants and populate the deeper layers of the cortex along the entire rostrol/caudal axis.  
scale bar = 200um.
84
85
Figure 5.2.  GSK-3 signaling is dispensable for tangential migration, but required for 
radial hippocampal migration.
(A-A’) E19.5 coronal sections showing EYFP-expressing interneurons in heterozygous 
control and GSK-3:DLX5/6 mutants crossed with the Ai3 reporter line.  GSK-3 deleted 
interneurons (green) enter the cortex in two streams as in controls (arrowheads) and showed 
no overt migration defect.  Nuclei were counterstained with Hoechst.  (n=3) 
(B-B’) E19 coronal sections showing CTIP2 (green) expressing neurons in the hippocampus.  
In the GSK-3:Nex mutants, the pyramidal cell layer (green) does not extend laterally into a 
compact CA1 region and remains dispersed (arrowheads).   Fimbrial axonal projections 
appear normal in GSK-3:Nex mutants (arrow).  Nuclei were counterstained with DRAQ5.  
Scale bar = 500um.  (n=3)
(C-C’) Higher magnification of hippocampal area shown in (B).  The GSK-3:Nex mutants 
show disrupted cytoarchitecture.  In the mutants, DRAQ5 labeled cells are mislocalized and 
diffuse (arrowheads) and fail to form clearly defined CA1/CA3 regions of the hippocampus.  
The GSK-3:Nex mutant mice also lack a clearly defined hippocampal sulcus (green bars) and 
dentate gyrus (DG).
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Figure 5.3  GSK-3 regulation of cortical lamination is cell autonomous and persistent.
(A-A’) E19 coronal sections after in utero electroporation at E14.5 with NeuroD-Cre and Z/
EG plasmids.  Electroporated cells were visualized with anti- EGFP (green) and nuclei were 
stained with DAPI (blue).  GSK-3 deleted neurons remain in the deeper layers of the cortex 
but elaborate a long pial-directed process (yellow arrows). scale bar = 200um   (n=5, two 
independent litters)  
(B-B’) Coronal section at P10 after E14.5 electroporation, as in A.  GSK-3 deleted neurons 
remain in the deeper layers of the cortical plate and fail to reach layer 2/3 (denoted with 
yellow bars). scale bar = 200um  (n=3, two independent litters)  
(C) Higher magnification of GSK-3 deleted neurons in B’ (large box).   GSK-3 deleted 
neurons in deeper layers co-label with Cux (red) (orange arrows), extend axons towards the 
corpus callosum and elaborate apical dendrites (yellow arrowheads). 
(D) Higher magnification of GSK-3 deleted neurons dendritic arbors in layer 1 (arrowheads) 
of GSK-3 deleted neuron in B’ (small box).  
 (E)  GSK-3 deletion delays multipolar to bipolar transition.  Still images from time-lapse 
imaging of organotypic slice cultures at 3DIV.  pCAG-dsRED or NeuroD-Cre;Z/EG were 
injected into the ventricles of GSK-3α-/-GSK-3βF/F embryos and electroporated at E15.  
Representative images were taken at time 0, 6, and 12 hours.  Control dsRed neurons migrate 
through the cortical plate (yellow, red and blue arrows show individual neurons at the 
different time points.)  (n=2 controls).  GSK-3 deleted neurons fail to migrate through the 
cortical plate and exhibit persistent multi-polar morphology (yellow arrowheads). (n=2 
control, n = 4 mutants) 
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Figure 5.4.  GSK-3 regulation of axon projections
(A)  Control and GSK-3 deleted neurons at P15 immunostained with antibodies against 
eGFP (black).  Electroporation was performed with the same methods and constructs as in 
Figure 3A using GSK3α+/+βloxp/loxp controls and either GSK-3α-/-GSK-3βloxp/loxp or GSK-3loxp 
mice for GSK-3 deletion.  n=3 from three litters.   
(B) Higher magnification of electroporated neuron region in A,A’ (dashed lines).  Control 
neurons populate the outer layers of the cortex while GSK-3 deleted neurons remain 
dispersed throughout all layers of the cortical plate. scale bar 200um 
(C)  High magnification of axonal arbors in A, A’ (box).  Control axons enter the cortical 
plate and densely arborize in layers 2/3 and 5 in the contralateral cortex.  GSK-3 deleted 
neurons extend axons that extend in the corpus callosum, but axonal arborization in 
contralateral cortex is sparse. scale bar 200um
(D) High magnification of axons in the corpus callosum from control and GSK-3 deleted 
neurons
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Figure 5.5  GSK-3 regulation of dendrite polarization.
(A)   Control and GSK-3 deleted neurons in the upper layers at P15, 
immunostained with antibodies against eGFP (black) using same methods as Figure 4.  
GSK-3 deleted neurons have abnormally polarized arbors.
(B)  Reconstructions of control and GSK-3 deleted neurons in the upper layers of the cortex.  
The axon (red) projects towards the ventricle in control and GSK-3 deleted neurons.  Apical 
dendrites (orange) and basal dendrites (blue) are more branched (arrows) and basal dendrites 
(blue) are mispolarized (arrowheads) in GSK-3 deleted neurons. 
(C-D) Basal dendrite and apical dendrite quantification.  Dendrogram shows that basal 
dendrites (C) frequently project towards the pial surface in GSK-3 deleted neurons.  (D) 
Apical dendrites project properly in GSK-3 deleted neurons but have abnormal morphology 
(see B).  (n=3, 15 control and 16 mutants quantified).
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Figure 5.6.  GSK-3 regulation of migration is independent of Wnt/B-catenin and RTK 
signaling.
(A) Coronal sections of somatosensory cortex at P20 stained with antibodies against NeuN.  
βcatEx3:Nex mutants exhibit  altered hippocampal cytoarchitecture with a rostral midline 
defect (arrow).  (n=3 from 3 independent litters). 
(B) High magnification of boxes in A.  Cux-1 neurons (red) are localized to layer 2/3 in both 
controls and βcatEx3:Nex mutants. 
(C)  Coronal sections of cortex showing DRAQ5 (blue) and Cux-1 (red) expressing neurons 
in Dvl123:Nex at E18.  Cux-1 neurons reach layer 2/3 in both controls and Dvl123:Nex triple 
mutants.  (n=3 from 2 independent litters).
(D) Wnt target gene expression in GSK-3:Nex cortex.  Cortical lysates were collected at E18 
for affymetrix microarray analysis.  GSK-3B exon expression was reduced as expected.  
Classic WNT target genes of (TCF)/LEF-1 transcription factors were unchanged.  
(E) Coronal sections of somatosensory cortex stained for Cux-1 (red) and Draq5 (blue).  
LKB1:Nex mutants: Cux-1 expressing neurons at P21 are localized in layer 2/3 (n=3).  
CDC42:Nex  and PTEN:Nex mutants: Cux-1 expressing neurons at P0 are normally localized 
(n=3).
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Figure 5.7.  Phosphorylation of GSK-3 Targets
A-A’) Western blots of P0 cortical lysates from GSK-3loxp:Nex mutants and GSK-3 α loxp/loxp β 
loxp/loxp controls.  Levels of GSK-3 proteins and phospho-target proteins are shown.  Strong 
reductions in phosphorylation of doublecortin on ser327/Thr321 and CRMP2 on Thr514 are 
evident.  A’ Quantification of relative densities from A. (n=3)
B-B’)  Western blots of cortical lysates at P0 showing levels of other GSK-3 targets.  No 
changes were observed in phosphorylation of dynamin, pCREB, pFAK, β-catenin.  No 
change was observed in cleaved caspase-3.  GAPDH was used as a loading control.  B’ 
Quantification of relative densities  (n=3)
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5.7 SUPPLEMENTAL FIGURES AND FIGURE LEGENDS
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Supplemental Figure 5.1.  Deletion of GSK-3 in the developing cortex resorts in 
lamination defects at multiple time points throughout development.
(A) Representative western blot confirms strongly reduced GSK-3β protein levels  in the E19 
GSK-3:Nex cortex compared to heterozygous control (n=3).  Duplicate protein samples 
shown.  Relative Density *p value < 0.05, unpaired t-test. 
(B)  Coronal cryostat sections at E16.  Layer 6 TBR1 neurons populate appropriate layers in 
control and GSK-3:NEX mutants(n=1).  Cux-1 (red) expressing neurons, marker for upper 
layer 2/3 neurons, are mislocalized in GSK-3:Nex mutant coronal sections (n=2). 
(C) Coronal vibratome sections showing Cux-1 expressing neurons at P3.  Neurons are 
mislocalized in GSK-3:Nex mutants (n=1).  Nuclei were counterstained with Hoechst.
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Supplemental Figure 5.2.  GSK-3loxp:Nex mice display altered lamination at P7.
(A)  P7 GSK-3loxp:Nex mutants stained with Cux1 (red) show altered lamination at with 
Cux1 expressing neurons spread throughout all layers of the cortex.  Littermate controls 
show normal Cux1 lamination in layer 2/3. Scale bar = 200um
(B)  Western blot of in P0 cortical lysates confirms strongly reduced total GSK-3 GSK-3α 
and GSK-3β proteins compared to GSK-3 α loxp/loxp β loxp/loxp controls.  No change in β-catenin 
levels was observed.  GAPDH was probed as a loading control  (n=3). 
(C)  P7 GSK-3loxp:Nex mice stained with Hoechst (blue) and GSK-3 (Red).  Control mice 
have GSK-3 spread throughout the cortical plate.  Littermate GSK-3loxp:Nex mutants show 
decreased GSK-3 staining throughout the cortical plate and high expression in layer 1. Scale 
bar = 200um 
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Supplemental Figure 5.3.  P10 Quantification of lamination in electroporated pups. 
(A)  Quantification of electroporated neurons in at P10 in upper versus lower layers of the 
cortex. (n=3, 4209 neurons counted)  ** p value = 0.003, unpaired t-test.  
(B)  Postnatal day 10 quantification of electroporated neurons in each cortical bin across the 
cortical plate.  Significant changes were found in deeper layer bins 1-2 and upper layer bins 
4-5, further indicating a failure of migration in the mutants. (n=3, 4209 neurons).  unpaired t-
test  * p = < 0.05, ** p=<0.01
(C)   Representative coronal section from control electroporated mouse (blue) co-labeled 
with MAP2 (red).  The cortex was divided into 5 cortical bins and the neurons populating 
each bin were counted using ImageJ
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Supplemental Figure 5.4.  GSK-3 deleted neurons polarize and are highly dynamic. 
(A)  Stage progression analysis of dissociated control and GSK-3 deleted neurons reveals no 
significant delay in polarization (n=3, 1341 neurons).
(B)  Live imaging of dissociated GSK-3 deleted neurons reveal dynamic neurites.  Images 
were taken every 11 minutes.  Representative images at time 0 (red), 220 minutes (blue), and 
440 minutes (green).  Merge Image is pseudo colored.
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Supplemental Figure 5.5.  In utero Experimental Procedure. 
A pregnant E13-E15.5 mouse is anesthetized and uterine horns exposed.  cDNA is injected 
into the lateral ventricles of the developing embryo and current is applied to direct the 
construct into the neuronal progenitors in the ventricular zone of the developing cortex.  The 
uterine horns are replaced internally for normal embryonic development to continue.  
Injected pups can be taken embryonically or postnatally for analysis.  Image above is a 
coronal vibratome section stained for dsRED and imaged at P3 to show normal lamination.
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CHAPTER 6: Discussion and Future Directions
6.1 Summary of Findings
 The most striking feature of my findings is the almost complete failure of radial 
migration in most GSK-3 deleted newly born cortical neurons.  Migration failure occurred 
even though initial stages of axon extension and dendritic arborization were not affected. 
This finding suggests very specific cytoskeletal regulation by GSK-3 rather disruption of all 
microtubule mediated processes. 
 Of course many molecules are required for radial migration.  However our 
preliminary findings with GSK-3 gain of function (data not shown, see below) suggest that 
GSK-3 may join a small group that are not only required, but are able to regulate the process.  
Further, GSK-3 appears to be important regulatory hub, being downstream of reelin and 
upstream of FAK and dynamin in potential regulation of adhesive properties.  More 
importantly, GSK-3 is implicated as working to together with CDK5 in the regulation key 
MAPs that are essential to migration.  The role of DCX is well established, but GSK-3 also 
strongly regulates CRMP-2.  The role of CRMP family members in migration has only 
recently been appreciated.
 GSK-3 also has important functions in aspects of neuronal morphogenesis, 
particularly dendritic orientation.  My work emphasizes the importance of GSK-3 kinase 
activity at several stages of cortical development from progenitor homeostasis (Kim et al., 
2009) to cortical lamination and morphogenesis. 
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6.2 Discussion
 Cortical migration is an extraordinarily complex process that requires proper sensing 
of migratory cues and rapid cytoskeletal rearrangement.  Both the classic Reelin cascade and 
other migration signaling cascades converge onto dynamic cytoskeletal regulation (Ayala, 
Shu et al. 2007; Barnes and Polleux 2009).  Multiple MAPs (Dehmelt and Halpain 2004), 
MAP1B (Del Rio, Gonzalez-Billault et al. 2004; Gonzalez-Billault, Del Rio et al. 2005), Lis1 
(Tsai, Chen et al. 2005), and DCX (Bai, Ramos et al. 2003; Tanaka, Serneo et al. 2004; 
Koizumi, Tanaka et al. 2006; Bilimoria, de la Torre-Ubieta et al. 2010) have all been 
identified and essential for proper lamination.  However signaling cascades upstream of these 
migration associated MAPs have not been fully defined.  
 Importantly for my findings, CDK5 is well known to regulate cortical neuronal 
migration (Dhavan and Tsai 2001; Xie, Sanada et al. 2003; Tanaka, Serneo et al. 2004; Xie, 
Samuels et al. 2006).  Further, CDK5 is known as a ‘priming‘ kinase for GSK-3 (Sengupta, 
Wu et al. 1997; Noble, Olm et al. 2003; Li, Hawkes et al. 2006).  Cdk5 phosphorylation of a 
substrate enhances GSK-3 function while in vitro inhibition of both GSK-3 and Cdk5 ablates 
the phosphorylation of downstream substrates (Gonzalez-Billault, Del Rio et al. 2005).  Cdk5 
has also been identified as a regulator of neuronal morphology in response to semaphorin 
signaling (Sasaki, Cheng et al. 2002).  Now, I have shown GSK-3 is a key regulator of 
neuronal migration and morphology, in a manner that may involve DCX and semaphorin 
signaling.  My data suggests that CDK5 priming and subsequent GSK-3 phosphorylation of 
DCX and CRMP-2 regulate radial migration.  My results provide a first step in elucidating a 
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model in which converging migratory cues siphon into one pathway reliant on GSK-3 
signaling and regulation of cytoskeletal elements.
 Interestingly, CDK5 is implicated in radial migration through via FAK, CRMP2 and 
DCX phosphorylation (Xie, Sanada et al. 2003; Tanaka, Serneo et al. 2004; Uchida, Ohshima 
et al. 2005).  Our GSK-3 mutants have a similar phenotype to the CDK5 mutants, an 
elongated multipolar stage followed by failed migration to the proper lamina and dendrite 
morphological abnormalities, though GSK-3 mutants appear to have a more severe defect.  
Although we saw no change in FAK phosphorylation, we do have significant changes in 
phosphorylation at GSK-3 sites of both DCX and CRMP-2.  These results may suggest that 
GSK-3 regulation of migration is cytoskeletal as opposed to adhesive.  
 A key validation of my idea would be a rescue of the GSK-3 deletion phenotype. 
Currently, we are cloning phosphomimetic versions of both DCX and CRMP-2 in the 
pNeuroD vector to perform these rescue experiments.  We hypothesize that phosphomimetic 
DCX expression could rescue the migration defect observed in the GSK-3 deleted neurons.  
We also hypothesize that phosphorylation of CRMP-2 may rescue the dendrite polarity, and 
possibly the axonal defects seen in GSK-3 deleted neurons.  Additionally, we will attempt a 
double expression of phosphomimetic versions of DCX and CRMP-2 in an attempt to rescue 
both the migration and morphology defects in the GSK-3 deleted neurons.  
 Another key validation experiment is that over-expression of GSK-3 should enhance 
migration.  Preliminary in utero over-expression experiments appear to show neurons with 
increased migration.  Overexpression analysis at E19.5 shows neurons in the outermost layer 
of the cortex and they appear more densely compacted in the boundary between layer II and 
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layer I (data not shown).  Obviously, this preliminary data must be replicated and quantified.  
However, it is promising that overexpression of GSK-3 would have the direct opposite effect 
from GSK-3 deletion.  Future experiments may include later time points to assess GSK-3s 
overexpression on morphology and axon targeting in vivo as well as assessment of CRMP-2 
and DCX via immunohistochemistry.
 We have shown that the defect in neuronal migration is independent of Wnt signaling.  
Interestingly, we also see no evidence that ser9 phoshorylation of GSK-3 is important for this 
phenotype.  We have found that PTEN, LKB1 and CDC42 regulation of GSK-3 are not 
required in vivo.  Interestingly, the GSK-3 deletion phenotype is similar to the migration and 
morphological phenotypes in mice were sema3A and NRP1 have been knocked down by 
siRNA.  Indeed, GSK-3 is an important mediator of semaphorin signaling (see chapter 3) 
suggesting that semaphorin signaling through GSK-3 may be partially responsible for the 
migration and morphological abnormalities we see in GSK-3 - deleted mice. 
6.2 Future Directions
Semaphorins and spines
 Though our work has not addressed the issue of spine development in GSK-3 deleted 
neurons, it is likely that GSK-3 regulation of microtubules could alter spine morphology and 
circuit function.  Importantly, disrupted semaphorin signaling increases dendritic spine 
numbers and alters morphology (Tran, Rubio et al. 2009).  As previously stated, semaphorin 
signaling activates GSK-3 therefore we would hypothesize that GSK-3 deleted mice would 
recapitulate dendritic spine morphology seen with disrupted sema signaling in vivo.   
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Long-term Depression
 Interestingly, GSK-3 is essential for LTD while GSK-3 over expression has been 
shown to block LTP (Hooper, Markevich et al. 2007; Peineau, Taghibiglou et al. 2007; Zhu, 
Wang et al. 2007), possibly through PSD-95 regulation (Nelson, Kim et al. 2013).  GSK-3 
has also been implicated in vivo to regulate endocytosis during periods of high activity 
(Clayton, Sue et al. 2010).  Therefore, we would expect changes in LTD and possibly LTP in 
neurons lacking GSK-3 expression.  Electrophysiological recordings to assess the function of 
GSK-3 deleted neurons could uncover another in vivo role for GSK-3 in the circuitry and 
signaling of mature neurons.
Long-term Survival
 We have seen no increase or decrease in cell death markers in embryonic and 
postnatal stages when migration is occurring.  However, for animals that survive for 
substantial times postnatally we begin to see appearance of apoptotic markers in the second 
postnatal week and evidence of neurodegeneration by P21.  This is very surprising as one 
would hypothesized, based on the literature, that GSK-3 inactivation would promote cell 
survical.  We do not yet know whether this is a cell autonomous effect.  This is an important 
area to pursue both for implications for the use of Lithium and because it goes completely 
against conventional wisdom as GSK-3 inhibition has previously been associated with 
increased survival rather than increased cell death.   
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Analog sensitive allele.  
 GSK-3 deletion in progenitors results in embryonic death while deletion in newly 
born neurons results in early postnatal death.  Therefore, in order to assess the role of GSK-3 
signaling in later stages of cortical function, a reversible GSK-3 inhibition will be crucial.  
An analog sensitive allele for GSK-3β recently became available from Taconic and has been 
used to study GSK-3 activity related axon degeneration in vitro (Chen, Maloney et al. 
2012).  This line help with uncovering novel roles for GSK-3 signaling in mature neurons in 
vivo, and would also allow for behavioral studies that are impossible due to the early death of 
our genetically deleted lines.
Lithium and GSK-3 inhibitors in humans
 Finally, GSK-3 is already known to be an interesting target for therapeutic 
intervention.  Lithium, which targets GSK-3 in the CNS, has been used for years to treat 
bipolar disorder (Klein and Melton 1996; O'Brien, Harper et al. 2004)(Stambolic, Ruel et al. 
1996; De Sarno, Li et al. 2002; Freland and Beaulieu 2012).  GSK-3 is expressed in all 
tissues and, in the developing cortex, and as we have shown, is a critical regulator of almost 
every facet of neuronal development.  While lithium affects dopamine receptor signaling: our 
work suggests that it may also affect neural proliferation in adulthood (Kim, Wang et al. 
2009).  Our future work will shortly sort out GSK-3 regulation of spines, LTD and survival.  
Known effects and potential effects related to structural change would suggest increased 
caution in using the drug.
(Rubenstein 2011)(Molnar 2011)(Bentivoglio and Mazzarello 1999)(Marin and Rubenstein 
2003)(Evsyukova, Plestant et al. 2013)(Stiess and Bradke 2011)
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